data_1dum_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dum _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.581 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -118.23 -20.08 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.23 -1.159 . . . . 0.0 109.473 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 1.2 m-85 -88.34 -24.94 22.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.126 -0.984 . . . . 0.0 109.761 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.571 ' CD2' HG13 ' B' ' 20' ' ' ILE . 4.0 mt -118.03 15.87 14.18 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 108.878 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.601 ' CD2' ' N ' ' A' ' 7' ' ' HIS . 0.1 OUTLIER -149.39 13.48 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.39 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.287 -0.883 . . . . 0.0 109.408 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.623 ' CB ' ' CB ' ' B' ' 16' ' ' TRP . . . -63.76 -62.76 1.44 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.245 -0.909 . . . . 0.0 109.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -37.57 -54.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.784 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 10' ' ' LYS . 19.1 mmtt -44.39 -67.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.1 m-85 -59.31 -33.95 71.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.573 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.06 -34.89 3.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.09 -25.49 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -1.017 . . . . 0.0 109.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.68 -47.61 6.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.114 -0.992 . . . . 0.0 110.093 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.691 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -59.04 -43.98 91.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 109.534 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.613 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -63.8 -49.71 80.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.453 -1.405 . . . . 0.0 108.696 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.92 -13.27 18.35 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.8 tp10 -89.47 -68.1 0.8 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.539 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.8 mt -75.22 -45.54 41.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 1.5 tmm? -59.81 -22.44 62.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 32.2 t30 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.583 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -146.36 -41.37 0.2 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 10.1 m-85 -67.85 -15.65 63.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.713 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.549 HD22 ' CG ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -112.16 -11.74 13.74 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.439 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -129.02 -11.12 4.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.882 -1.136 . . . . 0.0 110.225 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 -31.09 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.856 -1.152 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -77.16 -61.91 1.83 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 108.969 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -40.58 -51.97 2.9 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.232 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -50.23 -64.74 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.935 -1.103 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' B' ' 16' ' ' TRP . 4.9 m-30 -64.12 -34.05 77.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 109.155 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.628 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -42.32 -38.26 2.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -17.67 24.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.7 -45.23 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.908 -1.12 . . . . 0.0 110.531 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.668 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -54.9 -43.76 73.54 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.127 -0.983 . . . . 0.0 109.578 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.612 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -59.73 -52.92 55.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.093 -1.004 . . . . 0.0 108.634 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.8 -18.21 8.01 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' B' ' 16' ' ' TRP . 4.3 mm-40 -87.06 -65.64 0.99 Allowed 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.382 -1.069 . . . . 0.0 108.332 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 6' ' ' LEU . 10.7 mt -73.04 -49.92 35.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.775 0.798 . . . . 0.0 109.295 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.562 ' N ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 O-C-N 121.812 -0.555 . . . . 0.0 109.864 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.559 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.87 -41.34 0.06 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 1.9 m-85 -82.31 -10.9 58.92 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 1.6 mm? -114.06 10.06 17.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.663 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.559 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 19.1 m-70 -131.14 -31.64 1.66 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.112 -0.992 . . . . 0.0 110.076 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -127.6 -29.96 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 109.853 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.646 ' HB2' ' CG ' ' B' ' 16' ' ' TRP . . . -51.19 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.077 -1.015 . . . . 0.0 108.841 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' ALA . 18.7 tttp -29.16 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.637 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 8' ' ' SER . 13.6 mttm -55.66 -64.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.958 -1.089 . . . . 0.0 108.335 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 1.4 m-85 -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.611 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -51.06 -44.67 51.16 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 15.0 mmmt -85.75 -13.31 48.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -100.21 -49.41 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.64 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.8 p-90 -60.42 -41.68 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 110.36 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -58.24 -53.11 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.076 . . . . 0.0 108.846 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -54.27 -17.25 7.66 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 8.6 mm-40 -88.95 -65.42 1.02 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.374 -1.074 . . . . 0.0 108.438 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.566 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 15.7 mt -71.7 -49.64 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.548 0.69 . . . . 0.0 109.677 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -56.58 -20.32 20.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 109.812 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 8.0 t30 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.628 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.576 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.61 -46.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -1.051 . . . . 0.0 108.278 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.64 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 4.5 m-85 -70.02 -15.31 62.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.522 -0.736 . . . . 0.0 109.066 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -113.71 6.56 16.88 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.11 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.576 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 11.9 m-70 -141.29 12.91 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 109.908 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' SER . . . . . 0.439 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.0 OUTLIER -164.89 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.597 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -62.11 -63.52 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.015 . . . . 0.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.51 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 6.2 ttpt -33.24 -44.72 0.13 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.237 0.541 . . . . 0.0 110.048 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -52.1 -66.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' B' ' 16' ' ' TRP . 1.4 m-85 -69.33 -17.93 63.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.59 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -57.06 -39.8 90.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -88.21 -37.85 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.054 . . . . 0.0 109.968 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.92 -47.21 21.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.646 ' CG ' ' HB2' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.8 -50.57 70.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.609 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -68.57 -43.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.744 -1.222 . . . . 0.0 108.049 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.8 -13.47 18.59 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' B' ' 19' ' ' GLU . 1.1 tp10 -91.89 -68.82 0.77 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.546 ' HB ' ' HZ3' ' B' ' 16' ' ' TRP . 60.0 mt -73.15 -47.2 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.888 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.532 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 1.9 tmm? . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 tttt 175.84 -48.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 4.5 m-85 -69.92 -14.29 62.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.488 ' CD1' ' CG1' ' B' ' 20' ' ' ILE . 0.7 OUTLIER -114.31 -1.48 13.55 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.496 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 7.1 m-70 -134.84 10.37 3.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.879 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.534 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.9 t -157.98 -37.66 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB3' ' CG ' ' B' ' 16' ' ' TRP . . . -63.06 -64.19 0.98 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.046 -1.034 . . . . 0.0 108.942 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -30.24 -51.97 0.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.105 0.479 . . . . 0.0 110.284 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -47.14 -67.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 8' ' ' SER . 3.2 m-85 -66.16 -39.16 89.56 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.609 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.81 -32.76 2.29 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -96.67 -15.54 21.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -103.38 -48.09 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.906 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.686 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.3 p-90 -58.72 -43.04 90.01 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -57.18 -52.0 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.042 -1.036 . . . . 0.0 109.1 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.14 -15.51 10.83 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.9 mm-40 -91.32 -64.11 1.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.378 -1.072 . . . . 0.0 108.71 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.574 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 6.1 mt -71.48 -50.57 39.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.509 0.671 . . . . 0.0 110.132 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.56 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -63.27 -19.67 64.78 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.4 -0.812 . . . . 0.0 109.742 -178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 35.6 t30 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 109.5 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.573 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 3' ' ' GLY . 25.1 tttt 175.31 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 1.9 m-85 -76.01 -17.09 59.83 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.528 HD12 ' CG1' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -112.69 14.34 20.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.434 -0.791 . . . . 0.0 109.779 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.573 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 18.2 m-70 -142.36 -32.97 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.208 -0.932 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -119.25 -32.38 4.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.757 -1.214 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.599 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -61.1 -67.18 0.43 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.048 -1.033 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' B' ' 9' ' ' ALA . 8.6 ptmm? -30.85 -39.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.075 -0.391 . . . . 0.0 110.877 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.509 ' N ' ' HG3' ' B' ' 10' ' ' LYS . 0.4 OUTLIER -62.01 -62.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.788 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 1.1 m-85 -71.16 -31.85 68.2 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.634 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -46.94 -38.01 9.99 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -91.52 -20.35 21.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -1.128 . . . . 0.0 110.339 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -92.17 -56.8 2.92 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -49.83 -46.02 50.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.774 -0.579 . . . . 0.0 109.657 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.616 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -56.93 -53.39 43.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.244 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -54.13 -17.72 8.14 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 9.3 mm-40 -88.33 -66.42 0.92 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -1.209 . . . . 0.0 108.301 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.575 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 29.8 mt -71.22 -49.21 49.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.617 0.723 . . . . 0.0 109.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.545 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.747 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.526 ' HA2' ' NE2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.22 -41.56 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.532 -0.981 . . . . 0.0 108.472 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.77 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 14.4 m-85 -69.9 -24.84 63.46 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.389 0.614 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.541 ' C ' ' CG ' ' A' ' 7' ' ' HIS . 0.8 OUTLIER -111.73 20.55 16.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.346 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.541 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 1.5 m-70 -151.61 -28.42 0.18 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.341 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.6 -2.59 4.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.698 -1.251 . . . . 0.0 110.266 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.597 ' HB1' ' CB ' ' B' ' 16' ' ' TRP . . . -92.24 -63.8 1.19 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.066 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 1.4 ttmt -36.46 -46.15 0.54 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.487 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -51.03 -65.46 0.55 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 0.0 109.177 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.5 m-85 -70.96 -22.8 62.16 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -53.48 -35.21 50.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.31 -27.47 18.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -1.018 . . . . 0.0 110.274 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.89 -47.73 7.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.954 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.64 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.2 OUTLIER -59.76 -43.44 94.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.253 -0.905 . . . . 0.0 109.451 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -68.36 -52.28 38.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.714 -1.241 . . . . 0.0 108.388 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -53.31 -16.74 5.07 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 4.5 tp10 -86.65 -72.44 0.5 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.549 ' CD1' HD11 ' B' ' 6' ' ' LEU . 79.5 mt -70.47 -47.45 65.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.685 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -51.93 -22.43 3.86 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.683 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 2.6 m-80 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.09 -1.007 . . . . 0.0 109.489 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.51 ' HG3' ' CD2' ' B' ' 5' ' ' TYR . 0.3 OUTLIER -137.1 -45.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -1.082 . . . . 0.0 108.445 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.64 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 8.2 m-85 -72.15 -14.58 61.86 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.549 HD11 ' CD1' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -111.58 5.43 19.39 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.159 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.59 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 16.8 m-70 -138.29 15.31 2.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.088 -1.008 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.94 -35.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.018 -1.051 . . . . 0.0 109.829 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.626 ' HB2' ' CG ' ' A' ' 16' ' ' TRP . . . -64.46 -64.06 0.97 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.239 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.514 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -33.57 -48.47 0.26 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.172 0.51 . . . . 0.0 110.035 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -53.48 -64.33 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.6 m-85 -63.95 -30.11 71.22 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.304 -0.872 . . . . 0.0 108.735 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.605 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.04 -40.61 28.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -97.36 -11.75 23.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.482 -1.01 . . . . 0.0 109.454 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -102.88 -5.48 23.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.928 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.77 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -109.9 -44.27 3.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.232 -0.917 . . . . 0.0 109.285 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.657 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -59.02 -52.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.428 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.72 -18.39 8.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 30.8 mm-40 -88.72 -65.28 1.03 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.382 -1.069 . . . . 0.0 108.647 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.531 ' CG1' HD13 ' A' ' 6' ' ' LEU . 7.0 mt -70.56 -50.91 41.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.436 0.636 . . . . 0.0 110.191 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.576 ' CG ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 109.898 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HD2' ' C ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -147.26 -41.78 0.18 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.664 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 18.7 m-85 -68.51 -22.69 64.51 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' B' ' 20' ' ' ILE . 2.0 mm? -108.43 7.06 26.8 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 14.4 m-70 -140.31 12.51 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.031 -1.043 . . . . 0.0 109.75 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.85 -36.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.655 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -60.4 -70.89 0.15 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.151 -1.019 . . . . 0.0 108.71 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD3' ' CD1' ' B' ' 20' ' ' ILE . 5.3 mtpt -30.78 -53.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.078 0.466 . . . . 0.0 110.401 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' LYS . 8.5 mttt -45.69 -65.83 0.49 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' TRP . 10.4 m-85 -66.23 -30.22 70.62 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.6 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.65 -38.4 5.5 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -94.46 -18.49 21.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.426 -1.043 . . . . 0.0 109.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HB3' ' CE2' ' B' ' 5' ' ' TYR . . . -102.43 2.64 36.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.086 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.627 ' CD2' ' N ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -121.23 -47.03 2.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -60.84 -50.79 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.78 -15.8 14.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -91.32 -65.75 0.99 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.434 -1.039 . . . . 0.0 108.529 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.573 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 39.0 mt -73.1 -47.82 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.499 0.666 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -59.06 -18.47 35.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.73 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 27.4 m-20 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.22 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -10.88 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 108.995 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 2.0 m-85 -94.58 -17.74 22.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.374 -0.829 . . . . 0.0 109.256 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.534 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -114.9 16.68 17.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.094 -1.004 . . . . 0.0 109.529 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -152.81 -30.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 1.6 m -120.28 -5.18 9.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.805 -1.184 . . . . 0.0 109.798 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.608 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . . . -96.41 -58.75 1.98 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.15 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -39.64 -34.78 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.815 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -59.04 -66.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.253 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.541 ' O ' ' N ' ' B' ' 16' ' ' TRP . 11.6 m-85 -67.3 -20.85 65.68 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.592 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -51.45 -37.15 39.72 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -91.04 -41.26 11.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.605 -0.938 . . . . 0.0 109.988 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -45.32 29.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.02 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.73 -49.98 72.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.64 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -64.79 -52.77 50.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.679 -1.263 . . . . 0.0 109.399 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.574 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -52.26 -18.11 4.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' B' ' 20' ' ' ILE . 5.5 tp10 -87.21 -69.29 0.69 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.637 -0.919 . . . . 0.0 108.545 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.547 ' CD1' ' HD3' ' A' ' 10' ' ' LYS . 6.0 mt -68.5 -49.47 65.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.584 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 110.034 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 -41.89 0.27 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 10.7 m-85 -65.34 -20.82 66.56 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.53 -0.732 . . . . 0.0 109.035 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.5 mm? -107.66 5.25 26.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.888 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 9.1 m-70 -136.92 9.88 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.128 -0.982 . . . . 0.0 110.166 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.23 -36.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.062 -1.024 . . . . 0.0 109.823 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.637 ' HB2' ' CG ' ' B' ' 16' ' ' TRP . . . -63.16 -67.55 0.42 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.537 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 9' ' ' ALA . 14.0 mtpt -30.03 -56.74 0.18 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -44.29 -66.27 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 109.074 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.1 m-85 -66.21 -33.06 74.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.6 -32.36 1.98 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -26.88 13.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -1.143 . . . . 0.0 109.672 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 -46.11 8.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 0.0 109.873 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.661 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -60.12 -44.63 94.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.619 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -63.17 -50.28 79.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.501 -1.374 . . . . 0.0 109.014 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.51 -15.18 10.88 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -88.39 -69.08 0.72 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.541 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 68.2 mt -71.92 -48.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.565 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -54.94 -19.06 5.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.392 -0.817 . . . . 0.0 109.417 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 20.1 t-20 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.117 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -44.68 0.67 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.421 -1.046 . . . . 0.0 108.605 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 36.8 m-85 -64.16 -17.79 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.379 -0.826 . . . . 0.0 109.448 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 19' ' ' GLU . 1.3 mm? -110.37 -9.81 14.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 110.48 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.03 12.19 6.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.964 -1.085 . . . . 0.0 110.158 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.7 t -158.24 -37.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.028 -1.045 . . . . 0.0 110.108 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' A' ' 16' ' ' TRP . . . -66.18 -65.02 0.73 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -38.57 -47.88 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.633 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' B' ' 10' ' ' LYS . 1.3 mptm? -45.89 -68.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.8 m-85 -64.07 -29.82 70.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.576 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.89 -36.71 3.82 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -90.74 -29.96 17.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.94 -48.09 7.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.058 -1.026 . . . . 0.0 110.007 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.671 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -61.92 -44.71 96.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.573 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -66.75 -49.13 77.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.586 -1.321 . . . . 0.0 108.627 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -57.17 -15.43 14.76 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 3.5 tp10 -86.82 -72.5 0.5 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.533 ' HB ' ' HZ3' ' B' ' 16' ' ' TRP . 85.3 mt -70.11 -48.19 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.924 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.541 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -39.69 0.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 23.6 m-85 -66.8 -21.89 66.03 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.523 -0.736 . . . . 0.0 109.344 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.521 HD13 ' CD1' ' B' ' 20' ' ' ILE . 2.1 mm? -107.43 2.41 24.27 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -137.18 18.02 2.98 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 109.685 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -169.49 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 109.953 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.643 ' HB3' ' CG ' ' B' ' 16' ' ' TRP . . . -61.81 -66.75 0.49 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.064 -1.022 . . . . 0.0 108.88 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -30.31 -52.12 0.15 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.058 0.456 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' LYS . 4.0 mmtp -44.76 -67.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' A' ' 16' ' ' TRP . 3.3 m-85 -67.29 -33.54 75.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.63 -30.58 1.51 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.73 -34.29 10.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -1.103 . . . . 0.0 110.087 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 -38.18 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.895 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.622 ' CG ' ' HB2' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -71.02 -45.81 63.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 109.797 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.578 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -65.73 -51.06 66.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.45 -1.406 . . . . 0.0 108.803 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -55.92 -15.45 9.89 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -87.22 -71.32 0.57 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' CG1' HD12 ' B' ' 6' ' ' LEU . 79.0 mt -71.42 -47.67 57.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 1.6 tmm? -55.26 -19.51 8.54 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.91 -39.35 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.342 -1.093 . . . . 0.0 108.125 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 30.1 m-85 -68.93 -25.79 64.75 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.44 -0.787 . . . . 0.0 109.494 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' B' ' 6' ' ' LEU . 3.2 mm? -103.95 9.64 36.58 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.013 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' B' ' 6' ' ' LEU . 20.4 m-70 -138.47 13.34 2.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.955 -1.091 . . . . 0.0 110.156 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.16 -34.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 110.186 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.622 ' HB2' ' CG ' ' A' ' 16' ' ' TRP . . . -64.31 -66.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.107 -0.996 . . . . 0.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' B' ' 9' ' ' ALA . 8.3 mtpt -31.3 -50.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.142 0.496 . . . . 0.0 110.292 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.18 -64.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 108.833 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.1 m-85 -68.42 -22.23 64.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.576 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -56.25 -35.22 64.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -90.96 -29.03 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.091 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.24 -46.08 8.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.856 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.665 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.98 -47.69 82.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.347 -0.846 . . . . 0.0 109.407 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.559 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -68.94 -48.17 71.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.769 -1.207 . . . . 0.0 108.026 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.454 ' N ' HG12 ' B' ' 17' ' ' VAL . . . -55.83 -16.85 13.38 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.831 -2.107 . . . . 0.0 107.831 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -87.69 -71.9 0.55 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.535 ' N ' ' HG3' ' B' ' 19' ' ' GLU . 49.9 mt -70.73 -48.13 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.708 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 1.5 tmm? . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 -40.64 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 35.1 m-85 -63.98 -20.68 66.07 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' B' ' 20' ' ' ILE . 1.4 mm? -109.65 2.38 20.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.161 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -137.21 13.64 3.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -165.26 -36.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.091 -1.005 . . . . 0.0 110.142 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.631 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -63.54 -68.22 0.36 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.043 -1.035 . . . . 0.0 108.719 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -28.67 -48.05 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.144 0.497 . . . . 0.0 110.542 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -54.12 -63.2 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.117 -0.99 . . . . 0.0 108.701 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.0 m-30 -69.82 -34.08 73.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.613 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -45.97 -38.51 8.22 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -95.07 -11.41 28.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.233 -1.157 . . . . 0.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -104.6 -52.14 2.94 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 109.841 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.2 p-90 -50.18 -42.77 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.495 -0.753 . . . . 0.0 109.435 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -54.3 -51.22 50.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -57.87 -14.03 15.22 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 23.7 mm-40 -92.92 -61.57 1.56 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -1.118 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.579 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 4.3 mt -74.51 -49.92 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.44 0.638 . . . . 0.0 110.071 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.555 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 1.5 ppp? -64.14 -15.74 60.4 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.615 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 61.7 t30 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.361 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 8' ' ' SER . 0.2 OUTLIER -129.18 -39.36 1.54 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 19.2 m-85 -59.44 -23.12 62.41 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.654 -0.654 . . . . 0.0 109.244 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.502 ' N ' HD21 ' B' ' 6' ' ' LEU . 0.8 OUTLIER -113.34 -4.89 13.6 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.569 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -134.92 1.19 2.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.939 -1.1 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' SER . . . . . 0.513 ' N ' ' O ' ' B' ' 4' ' ' LYS . 14.5 m -141.9 -38.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -67.2 -63.31 1.09 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 108.952 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' ALA . 6.9 ptmt -33.31 -48.72 0.25 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' B' ' 10' ' ' LYS . 23.6 mmtt -56.0 -61.15 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.103 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' B' ' 16' ' ' TRP . 1.7 m-85 -67.27 -27.03 66.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.29 -43.47 34.13 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -22.34 25.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -1.036 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.67 -49.54 5.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.068 . . . . 0.0 109.971 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.653 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -61.09 -45.95 92.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 109.364 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -63.57 -48.75 85.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.595 -1.316 . . . . 0.0 108.62 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.1 -13.38 14.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -90.63 -67.85 0.82 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.568 -0.96 . . . . 0.0 108.642 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 6' ' ' LEU . 60.8 mt -75.88 -40.06 38.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.984 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.328 -0.857 . . . . 0.0 109.93 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . 0.441 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -133.39 -35.01 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -1.052 . . . . 0.0 108.538 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 1.9 m-85 -75.04 -20.5 59.54 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.47 -0.769 . . . . 0.0 109.367 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 6' ' ' LEU . 1.1 mm? -114.65 6.91 15.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.162 -0.962 . . . . 0.0 109.908 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 3.4 m-70 -147.84 14.78 1.06 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.334 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -159.95 -39.42 0.05 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.418 -0.801 . . . . 0.0 109.125 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' B' ' 16' ' ' TRP . . . -61.75 -65.77 0.64 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 108.951 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -25.0 -54.15 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.19 0.519 . . . . 0.0 110.763 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -49.03 -64.26 0.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 108.816 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -71.44 -36.99 71.44 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.588 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.86 -33.4 2.55 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HE2' ' CH2' ' B' ' 16' ' ' TRP . 2.2 mptp? -95.11 -22.92 17.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -1.098 . . . . 0.0 109.841 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.76 -47.95 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 0.0 109.758 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.667 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.968 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.575 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -67.61 -49.86 66.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.732 -1.23 . . . . 0.0 108.29 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.75 -14.79 10.44 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.4 tp10 -88.58 -71.61 0.58 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.557 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 67.4 mt -70.4 -48.18 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.551 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 2.8 tmm? -52.41 -20.5 2.87 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.349 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 -47.54 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 20.6 m-85 -62.07 -17.78 58.59 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -109.45 -2.27 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.055 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.36 19.11 3.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.688 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' SER . . . . . 0.517 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.5 OUTLIER -167.27 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 110.063 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.616 ' HB2' ' CG ' ' A' ' 16' ' ' TRP . . . -66.82 -62.53 1.39 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.991 -1.068 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -35.05 -47.19 0.36 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.134 0.492 . . . . 0.0 109.979 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -51.74 -56.12 15.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.105 -0.997 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 7.7 m-85 -68.83 -30.96 69.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.606 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -44.6 -44.35 8.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -87.29 -19.21 28.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -1.021 . . . . 0.0 109.922 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -98.93 -0.06 42.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.623 ' CG ' ' HB2' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -119.21 -47.37 2.47 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.283 -0.886 . . . . 0.0 108.611 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -63.79 -41.49 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.42 ' C ' ' OE1' ' B' ' 19' ' ' GLU . . . -65.56 -6.02 26.51 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 3.1 mm-40 -105.94 -68.52 0.87 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.208 -1.172 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.593 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 25.5 mt -64.29 -52.29 57.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.617 0.723 . . . . 0.0 109.904 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 O-C-N 121.504 -0.747 . . . . 0.0 109.86 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -134.12 -43.81 0.79 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.567 -0.961 . . . . 0.0 108.517 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.636 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 8.5 m-85 -67.54 -20.41 65.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -100.42 -1.4 35.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' HIS . . . . . 0.409 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 16.3 m-70 -136.84 -30.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 110.124 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' LYS . 1.1 t -106.12 -32.87 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.025 . . . . 0.0 109.636 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.611 ' CB ' ' HA ' ' A' ' 5' ' ' TYR . . . -76.24 -59.42 2.77 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.182 -0.948 . . . . 0.0 109.16 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.489 ' HD3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -40.4 -35.25 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.541 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HE2' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -61.51 -64.17 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -66.82 -34.04 76.93 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.616 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -42.4 -37.82 2.65 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -21.01 20.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.404 -1.057 . . . . 0.0 110.287 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -95.15 -52.93 3.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.044 -1.035 . . . . 0.0 110.277 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TRP . . . . . 0.714 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.4 p-90 -51.31 -42.63 61.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.551 -0.718 . . . . 0.0 109.87 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -56.25 -51.0 68.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 108.923 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.03 -14.26 16.94 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 35.2 mm-40 -90.01 -63.93 1.21 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.261 -1.141 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.581 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 18.8 mt -74.6 -49.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.582 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.74 -11.22 53.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.723 -0.611 . . . . 0.0 110.334 -178.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 9.2 t30 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.075 . . . . 0.0 109.481 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -114.29 -19.48 11.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.949 -1.324 . . . . 0.0 108.815 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 3.9 m-85 -79.58 -25.0 41.66 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.468 -0.77 . . . . 0.0 109.774 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' LEU . . . . . 0.547 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 1.1 mm? -111.26 12.84 21.72 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.014 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' HIS . . . . . 0.547 ' CG ' ' C ' ' B' ' 6' ' ' LEU . 4.5 m-70 -152.66 16.95 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.133 -0.98 . . . . 0.0 109.45 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -165.6 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.216 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ALA . . . . . 0.613 ' CB ' ' HA ' ' B' ' 5' ' ' TYR . . . -61.98 -65.84 0.63 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.087 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LYS . . . . . 0.532 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -31.73 -44.41 0.08 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.709 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -64.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 108.994 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -70.68 -37.75 73.68 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . 0.619 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.07 -36.63 2.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -97.72 -13.36 21.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -1.141 . . . . 0.0 109.983 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.44 -49.87 3.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.0 109.639 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' TRP . . . . . 0.636 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -51.72 -43.94 63.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.793 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.634 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -58.21 -48.89 83.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.067 -1.021 . . . . 0.0 108.894 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.32 -13.63 16.54 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 3.9 mm-40 -93.9 -65.43 0.99 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.509 -0.995 . . . . 0.0 108.651 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.573 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 5.4 mt -69.38 -50.36 52.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.504 0.668 . . . . 0.0 109.548 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.799 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.458 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.458 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 4.6 mt 64.19 131.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -1.19 . . . . 0.0 109.61 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.581 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . 146.55 -14.28 1.6 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -118.23 -20.08 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.23 -1.159 . . . . 0.0 109.473 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.668 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 1.2 m-85 -88.34 -24.94 22.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.126 -0.984 . . . . 0.0 109.761 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.571 ' CD2' HG13 ' B' ' 20' ' ' ILE . 4.0 mt -118.03 15.87 14.18 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 108.878 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.601 ' CD2' ' N ' ' A' ' 7' ' ' HIS . 0.1 OUTLIER -149.39 13.48 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.39 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.287 -0.883 . . . . 0.0 109.408 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.623 ' CB ' ' CB ' ' B' ' 16' ' ' TRP . . . -63.76 -62.76 1.44 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.245 -0.909 . . . . 0.0 109.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.553 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -37.57 -54.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.784 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 10' ' ' LYS . 19.1 mmtt -44.39 -67.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.1 m-85 -59.31 -33.95 71.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.573 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.06 -34.89 3.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.09 -25.49 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -1.017 . . . . 0.0 109.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.68 -47.61 6.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.114 -0.992 . . . . 0.0 110.093 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.691 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -59.04 -43.98 91.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 109.534 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.613 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -63.8 -49.71 80.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.453 -1.405 . . . . 0.0 108.696 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.92 -13.27 18.35 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.8 tp10 -89.47 -68.1 0.8 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.539 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 63.8 mt -75.22 -45.54 41.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 1.5 tmm? -59.81 -22.44 62.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 32.2 t30 -80.84 -33.01 34.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.466 ' O ' ' HB ' ' B' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' B' ' 1' ' ' GLY . 1.9 mp 62.44 91.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -1.092 . . . . 0.0 109.743 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.14 24.45 0.32 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.415 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -146.36 -41.37 0.2 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.691 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 10.1 m-85 -67.85 -15.65 63.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.713 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.549 HD22 ' CG ' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -112.16 -11.74 13.74 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.439 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -129.02 -11.12 4.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.882 -1.136 . . . . 0.0 110.225 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 -31.09 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.856 -1.152 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -77.16 -61.91 1.83 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 108.969 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -40.58 -51.97 2.9 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.232 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -50.23 -64.74 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.935 -1.103 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' B' ' 16' ' ' TRP . 4.9 m-30 -64.12 -34.05 77.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 109.155 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.628 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -42.32 -38.26 2.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -17.67 24.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.469 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.7 -45.23 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.908 -1.12 . . . . 0.0 110.531 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.668 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -54.9 -43.76 73.54 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.127 -0.983 . . . . 0.0 109.578 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.612 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -59.73 -52.92 55.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.093 -1.004 . . . . 0.0 108.634 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.8 -18.21 8.01 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.524 ' HG3' ' HA ' ' B' ' 16' ' ' TRP . 4.3 mm-40 -87.06 -65.64 0.99 Allowed 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.382 -1.069 . . . . 0.0 108.332 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.571 HG13 ' CD2' ' A' ' 6' ' ' LEU . 10.7 mt -73.04 -49.92 35.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.775 0.798 . . . . 0.0 109.295 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.562 ' N ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -57.76 -23.96 54.72 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.812 -0.555 . . . . 0.0 109.864 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' B' ' 18' ' ' GLY . 13.5 t30 -101.93 -34.5 9.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.481 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mt -136.14 140.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -1.113 . . . . 0.0 109.312 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.559 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . 118.42 31.69 1.48 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.87 -41.34 0.06 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.595 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 1.9 m-85 -82.31 -10.9 58.92 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 1.6 mm? -114.06 10.06 17.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.663 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.559 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 19.1 m-70 -131.14 -31.64 1.66 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.112 -0.992 . . . . 0.0 110.076 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -127.6 -29.96 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 109.853 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.646 ' HB2' ' CG ' ' B' ' 16' ' ' TRP . . . -51.19 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.077 -1.015 . . . . 0.0 108.841 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' ALA . 18.7 tttp -29.16 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.637 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 8' ' ' SER . 13.6 mttm -55.66 -64.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.958 -1.089 . . . . 0.0 108.335 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 1.4 m-85 -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.611 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -51.06 -44.67 51.16 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 15.0 mmmt -85.75 -13.31 48.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -100.21 -49.41 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.64 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.8 p-90 -60.42 -41.68 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 110.36 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -58.24 -53.11 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.076 . . . . 0.0 108.846 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -54.27 -17.25 7.66 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 8.6 mm-40 -88.95 -65.42 1.02 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.374 -1.074 . . . . 0.0 108.438 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.566 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 15.7 mt -71.7 -49.64 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.548 0.69 . . . . 0.0 109.677 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.516 ' N ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -56.58 -20.32 20.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 109.812 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 8.0 t30 -102.25 -36.86 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.628 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.496 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.493 ' CG2' ' OE1' ' A' ' 19' ' ' GLU . 5.6 pt -111.56 92.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.296 -1.12 . . . . 0.0 109.5 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.576 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . -126.43 25.07 5.47 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.61 -46.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -1.051 . . . . 0.0 108.278 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.64 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 4.5 m-85 -70.02 -15.31 62.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.522 -0.736 . . . . 0.0 109.066 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -113.71 6.56 16.88 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.11 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.576 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 11.9 m-70 -141.29 12.91 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 109.908 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.439 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.0 OUTLIER -164.89 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.597 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -62.11 -63.52 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.015 . . . . 0.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.51 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 6.2 ttpt -33.24 -44.72 0.13 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.237 0.541 . . . . 0.0 110.048 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -52.1 -66.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' B' ' 16' ' ' TRP . 1.4 m-85 -69.33 -17.93 63.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.59 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -57.06 -39.8 90.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -88.21 -37.85 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.054 . . . . 0.0 109.968 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.92 -47.21 21.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.646 ' CG ' ' HB2' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.8 -50.57 70.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.609 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -68.57 -43.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.744 -1.222 . . . . 0.0 108.049 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' B' ' 22' ' ' ASN . . . -58.8 -13.47 18.59 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' B' ' 19' ' ' GLU . 1.1 tp10 -91.89 -68.82 0.77 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.546 ' HB ' ' HZ3' ' B' ' 16' ' ' TRP . 60.0 mt -73.15 -47.2 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.888 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.532 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 1.9 tmm? -53.97 -24.67 17.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER -72.22 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 109.452 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.57 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.71 83.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -1.101 . . . . 0.0 109.54 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.496 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -137.18 55.8 0.69 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 tttt 175.84 -48.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.648 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 4.5 m-85 -69.92 -14.29 62.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.488 ' CD1' ' CG1' ' B' ' 20' ' ' ILE . 0.7 OUTLIER -114.31 -1.48 13.55 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.496 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 7.1 m-70 -134.84 10.37 3.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.879 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.534 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.9 t -157.98 -37.66 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.615 ' HB3' ' CG ' ' B' ' 16' ' ' TRP . . . -63.06 -64.19 0.98 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.046 -1.034 . . . . 0.0 108.942 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -30.24 -51.97 0.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.105 0.479 . . . . 0.0 110.284 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -47.14 -67.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 8' ' ' SER . 3.2 m-85 -66.16 -39.16 89.56 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.609 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.81 -32.76 2.29 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -96.67 -15.54 21.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -103.38 -48.09 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.906 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.686 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.3 p-90 -58.72 -43.04 90.01 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -57.18 -52.0 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.042 -1.036 . . . . 0.0 109.1 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.14 -15.51 10.83 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.9 mm-40 -91.32 -64.11 1.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.378 -1.072 . . . . 0.0 108.71 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.574 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 6.1 mt -71.48 -50.57 39.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.509 0.671 . . . . 0.0 110.132 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.56 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -63.27 -19.67 64.78 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.4 -0.812 . . . . 0.0 109.742 -178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.459 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 35.6 t30 -109.19 9.23 26.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 109.5 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 26.8 t . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.586 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.47 ' CG2' ' HG ' ' B' ' 6' ' ' LEU . 2.5 mp -95.45 85.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 109.627 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.573 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . -142.14 59.5 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 3' ' ' GLY . 25.1 tttt 175.31 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.686 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 1.9 m-85 -76.01 -17.09 59.83 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.528 HD12 ' CG1' ' A' ' 20' ' ' ILE . 0.7 OUTLIER -112.69 14.34 20.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.434 -0.791 . . . . 0.0 109.779 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.573 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 18.2 m-70 -142.36 -32.97 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.208 -0.932 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -119.25 -32.38 4.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.757 -1.214 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.599 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -61.1 -67.18 0.43 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.048 -1.033 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.51 ' C ' ' O ' ' B' ' 9' ' ' ALA . 8.6 ptmm? -30.85 -39.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.075 -0.391 . . . . 0.0 110.877 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.509 ' N ' ' HG3' ' B' ' 10' ' ' LYS . 0.4 OUTLIER -62.01 -62.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.788 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 1.1 m-85 -71.16 -31.85 68.2 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.634 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -46.94 -38.01 9.99 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -91.52 -20.35 21.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -1.128 . . . . 0.0 110.339 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.538 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -92.17 -56.8 2.92 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.648 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -49.83 -46.02 50.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.774 -0.579 . . . . 0.0 109.657 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.616 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -56.93 -53.39 43.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.244 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -54.13 -17.72 8.14 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 9.3 mm-40 -88.33 -66.42 0.92 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -1.209 . . . . 0.0 108.301 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.575 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 29.8 mt -71.22 -49.21 49.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.617 0.723 . . . . 0.0 109.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.545 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 0.5 OUTLIER -55.13 -19.23 7.04 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.747 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 26.8 t30 -102.84 -21.89 13.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.214 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.354 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.455 HD12 HD22 ' A' ' 6' ' ' LEU . 3.9 tt -84.53 106.27 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.526 ' HA2' ' NE2' ' A' ' 7' ' ' HIS . . . -150.61 17.76 0.99 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.22 -41.56 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.532 -0.981 . . . . 0.0 108.472 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.77 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 14.4 m-85 -69.9 -24.84 63.46 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.389 0.614 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.541 ' C ' ' CG ' ' A' ' 7' ' ' HIS . 0.8 OUTLIER -111.73 20.55 16.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.346 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.541 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 1.5 m-70 -151.61 -28.42 0.18 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.341 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.6 -2.59 4.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.698 -1.251 . . . . 0.0 110.266 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.597 ' HB1' ' CB ' ' B' ' 16' ' ' TRP . . . -92.24 -63.8 1.19 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.066 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 1.4 ttmt -36.46 -46.15 0.54 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.487 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -51.03 -65.46 0.55 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 0.0 109.177 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.5 m-85 -70.96 -22.8 62.16 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -53.48 -35.21 50.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.31 -27.47 18.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -1.018 . . . . 0.0 110.274 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.89 -47.73 7.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.954 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.64 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.2 OUTLIER -59.76 -43.44 94.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.253 -0.905 . . . . 0.0 109.451 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.566 ' CG1' ' N ' ' A' ' 18' ' ' GLY . 0.3 OUTLIER -68.36 -52.28 38.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.714 -1.241 . . . . 0.0 108.388 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -53.31 -16.74 5.07 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 4.5 tp10 -86.65 -72.44 0.5 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.549 ' CD1' HD11 ' B' ' 6' ' ' LEU . 79.5 mt -70.47 -47.45 65.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.685 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.534 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -51.93 -22.43 3.86 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.683 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 2.6 m-80 -100.49 -23.8 14.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.09 -1.007 . . . . 0.0 109.489 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.519 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.483 HD12 ' N ' ' B' ' 2' ' ' ILE . 2.0 mp -113.51 174.66 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 109.386 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . 111.98 11.08 17.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.51 ' HG3' ' CD2' ' B' ' 5' ' ' TYR . 0.3 OUTLIER -137.1 -45.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -1.082 . . . . 0.0 108.445 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.64 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 8.2 m-85 -72.15 -14.58 61.86 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.549 HD11 ' CD1' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -111.58 5.43 19.39 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.159 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.59 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 16.8 m-70 -138.29 15.31 2.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.088 -1.008 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.94 -35.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.018 -1.051 . . . . 0.0 109.829 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.626 ' HB2' ' CG ' ' A' ' 16' ' ' TRP . . . -64.46 -64.06 0.97 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.239 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.514 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -33.57 -48.47 0.26 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.172 0.51 . . . . 0.0 110.035 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -53.48 -64.33 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.6 m-85 -63.95 -30.11 71.22 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.304 -0.872 . . . . 0.0 108.735 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.605 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.04 -40.61 28.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -97.36 -11.75 23.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.482 -1.01 . . . . 0.0 109.454 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.519 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -102.88 -5.48 23.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.928 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.77 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -109.9 -44.27 3.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.232 -0.917 . . . . 0.0 109.285 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.657 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -59.02 -52.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.428 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.72 -18.39 8.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 30.8 mm-40 -88.72 -65.28 1.03 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.382 -1.069 . . . . 0.0 108.647 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.531 ' CG1' HD13 ' A' ' 6' ' ' LEU . 7.0 mt -70.56 -50.91 41.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.436 0.636 . . . . 0.0 110.191 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.576 ' CG ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -59.69 -25.69 64.97 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 109.898 -178.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.484 ' N ' ' HG3' ' B' ' 21' ' ' MET . 35.1 t30 -96.74 -46.36 6.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.411 ' OXT' ' O ' ' B' ' 22' ' ' ASN . 9.2 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.29 86.88 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -1.177 . . . . 0.0 109.442 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.462 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -154.83 27.87 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HD2' ' C ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -147.26 -41.78 0.18 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.664 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 18.7 m-85 -68.51 -22.69 64.51 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD11 ' CD1' ' B' ' 20' ' ' ILE . 2.0 mm? -108.43 7.06 26.8 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 14.4 m-70 -140.31 12.51 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.031 -1.043 . . . . 0.0 109.75 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.85 -36.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.655 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -60.4 -70.89 0.15 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.151 -1.019 . . . . 0.0 108.71 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' HD3' ' CD1' ' B' ' 20' ' ' ILE . 5.3 mtpt -30.78 -53.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.078 0.466 . . . . 0.0 110.401 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' LYS . 8.5 mttt -45.69 -65.83 0.49 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' TRP . 10.4 m-85 -66.23 -30.22 70.62 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.6 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.65 -38.4 5.5 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -94.46 -18.49 21.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.426 -1.043 . . . . 0.0 109.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.577 ' HB3' ' CE2' ' B' ' 5' ' ' TYR . . . -102.43 2.64 36.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.086 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.627 ' CD2' ' N ' ' A' ' 17' ' ' VAL . 0.5 OUTLIER -121.23 -47.03 2.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -60.84 -50.79 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.78 -15.8 14.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -91.32 -65.75 0.99 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.434 -1.039 . . . . 0.0 108.529 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.573 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 39.0 mt -73.1 -47.82 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.499 0.666 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.526 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -59.06 -18.47 35.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.73 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 27.4 m-20 -103.55 -34.47 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.455 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.439 HD13 HG22 ' B' ' 2' ' ' ILE . 2.9 pt -149.11 73.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -1.189 . . . . 0.0 109.662 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.14 -17.92 2.93 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -10.88 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 108.995 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 2.0 m-85 -94.58 -17.74 22.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.374 -0.829 . . . . 0.0 109.256 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.534 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -114.9 16.68 17.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.094 -1.004 . . . . 0.0 109.529 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -152.81 -30.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 1.6 m -120.28 -5.18 9.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.805 -1.184 . . . . 0.0 109.798 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.608 ' HB2' ' CD1' ' A' ' 16' ' ' TRP . . . -96.41 -58.75 1.98 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.15 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.468 ' HD2' ' HG2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -39.64 -34.78 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.815 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' HD2' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -59.04 -66.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.253 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.541 ' O ' ' N ' ' B' ' 16' ' ' TRP . 11.6 m-85 -67.3 -20.85 65.68 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.592 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -51.45 -37.15 39.72 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -91.04 -41.26 11.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.605 -0.938 . . . . 0.0 109.988 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -45.32 29.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.02 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.664 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.73 -49.98 72.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.64 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -64.79 -52.77 50.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.679 -1.263 . . . . 0.0 109.399 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.574 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -52.26 -18.11 4.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' B' ' 20' ' ' ILE . 5.5 tp10 -87.21 -69.29 0.69 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.637 -0.919 . . . . 0.0 108.545 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.547 ' CD1' ' HD3' ' A' ' 10' ' ' LYS . 6.0 mt -68.5 -49.47 65.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.584 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.55 ' CG ' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -61.43 -19.03 61.51 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 110.034 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 1.8 m-20 -66.41 -58.32 5.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.976 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.535 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.518 ' O ' ' CG2' ' A' ' 2' ' ' ILE . 54.7 mt 56.83 41.54 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -1.141 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.45 1.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 -41.89 0.27 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.671 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 10.7 m-85 -65.34 -20.82 66.56 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.53 -0.732 . . . . 0.0 109.035 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.606 ' N ' ' CD2' ' A' ' 6' ' ' LEU . 3.5 mm? -107.66 5.25 26.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.888 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 9.1 m-70 -136.92 9.88 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.128 -0.982 . . . . 0.0 110.166 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.23 -36.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.062 -1.024 . . . . 0.0 109.823 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.637 ' HB2' ' CG ' ' B' ' 16' ' ' TRP . . . -63.16 -67.55 0.42 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.537 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' C ' ' O ' ' A' ' 9' ' ' ALA . 14.0 mtpt -30.03 -56.74 0.18 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -44.29 -66.27 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 109.074 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.1 m-85 -66.21 -33.06 74.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.575 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.6 -32.36 1.98 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -26.88 13.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -1.143 . . . . 0.0 109.672 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 -46.11 8.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 0.0 109.873 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.661 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -60.12 -44.63 94.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.619 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -63.17 -50.28 79.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.501 -1.374 . . . . 0.0 109.014 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.51 -15.18 10.88 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.59 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -88.39 -69.08 0.72 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.541 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 68.2 mt -71.92 -48.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.565 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -54.94 -19.06 5.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.392 -0.817 . . . . 0.0 109.417 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 20.1 t-20 -80.82 -35.85 32.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.117 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 20' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.331 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 5.3 mp 51.66 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 109.53 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.57 18.26 1.0 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -44.68 0.67 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.421 -1.046 . . . . 0.0 108.605 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.661 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 36.8 m-85 -64.16 -17.79 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.379 -0.826 . . . . 0.0 109.448 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.535 HD21 ' CG ' ' A' ' 19' ' ' GLU . 1.3 mm? -110.37 -9.81 14.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 110.48 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.03 12.19 6.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.964 -1.085 . . . . 0.0 110.158 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.7 t -158.24 -37.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.028 -1.045 . . . . 0.0 110.108 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.605 ' HB3' ' CB ' ' A' ' 16' ' ' TRP . . . -66.18 -65.02 0.73 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -38.57 -47.88 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.633 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.435 ' C ' ' O ' ' B' ' 10' ' ' LYS . 1.3 mptm? -45.89 -68.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.8 m-85 -64.07 -29.82 70.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.576 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.89 -36.71 3.82 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -90.74 -29.96 17.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.94 -48.09 7.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.058 -1.026 . . . . 0.0 110.007 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.671 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -61.92 -44.71 96.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.573 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -66.75 -49.13 77.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.586 -1.321 . . . . 0.0 108.627 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -57.17 -15.43 14.76 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 3.5 tp10 -86.82 -72.5 0.5 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.533 ' HB ' ' HZ3' ' B' ' 16' ' ' TRP . 85.3 mt -70.11 -48.19 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.924 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.541 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -55.26 -24.49 28.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 -179.329 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 44.5 t30 -83.54 -30.91 26.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.375 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.9 pt -79.85 115.44 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -1.151 . . . . 0.0 109.318 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.3 11.88 3.54 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -39.69 0.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.665 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 23.6 m-85 -66.8 -21.89 66.03 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.523 -0.736 . . . . 0.0 109.344 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.521 HD13 ' CD1' ' B' ' 20' ' ' ILE . 2.1 mm? -107.43 2.41 24.27 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -137.18 18.02 2.98 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 109.685 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -169.49 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 109.953 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.643 ' HB3' ' CG ' ' B' ' 16' ' ' TRP . . . -61.81 -66.75 0.49 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.064 -1.022 . . . . 0.0 108.88 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -30.31 -52.12 0.15 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.058 0.456 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' LYS . 4.0 mmtp -44.76 -67.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' A' ' 16' ' ' TRP . 3.3 m-85 -67.29 -33.54 75.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.63 -30.58 1.51 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.73 -34.29 10.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -1.103 . . . . 0.0 110.087 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.5 -38.18 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.895 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.622 ' CG ' ' HB2' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -71.02 -45.81 63.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 109.797 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.578 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -65.73 -51.06 66.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.45 -1.406 . . . . 0.0 108.803 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -55.92 -15.45 9.89 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.552 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -87.22 -71.32 0.57 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' CG1' HD12 ' B' ' 6' ' ' LEU . 79.0 mt -71.42 -47.67 57.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.529 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 1.6 tmm? -55.26 -19.51 8.54 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -78.68 -46.25 19.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . 0.463 HG21 HD12 ' B' ' 2' ' ' ILE . 1.8 pt -143.97 64.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.185 -1.186 . . . . 0.0 109.757 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.69 9.66 6.43 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.91 -39.35 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.342 -1.093 . . . . 0.0 108.125 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.613 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 30.1 m-85 -68.93 -25.79 64.75 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.44 -0.787 . . . . 0.0 109.494 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' B' ' 6' ' ' LEU . 3.2 mm? -103.95 9.64 36.58 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.013 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' B' ' 6' ' ' LEU . 20.4 m-70 -138.47 13.34 2.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.955 -1.091 . . . . 0.0 110.156 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -171.16 -34.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 110.186 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.622 ' HB2' ' CG ' ' A' ' 16' ' ' TRP . . . -64.31 -66.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.107 -0.996 . . . . 0.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.514 ' C ' ' O ' ' B' ' 9' ' ' ALA . 8.3 mtpt -31.3 -50.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.142 0.496 . . . . 0.0 110.292 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.18 -64.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 108.833 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.542 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.1 m-85 -68.42 -22.23 64.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.576 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -56.25 -35.22 64.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -90.96 -29.03 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.091 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.24 -46.08 8.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.856 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.665 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.98 -47.69 82.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.347 -0.846 . . . . 0.0 109.407 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.559 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -68.94 -48.17 71.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.769 -1.207 . . . . 0.0 108.026 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.454 ' N ' HG12 ' B' ' 17' ' ' VAL . . . -55.83 -16.85 13.38 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.831 -2.107 . . . . 0.0 107.831 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.538 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -87.69 -71.9 0.55 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.535 ' N ' ' HG3' ' B' ' 19' ' ' GLU . 49.9 mt -70.73 -48.13 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.708 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.542 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 1.5 tmm? -56.95 -19.25 16.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -60.25 2.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.108 -0.995 . . . . 0.0 109.287 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.501 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.3 mm 59.4 75.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -1.129 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.52 13.71 2.02 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 -40.64 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 35.1 m-85 -63.98 -20.68 66.07 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.532 HD13 ' CD1' ' B' ' 20' ' ' ILE . 1.4 mm? -109.65 2.38 20.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.161 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -137.21 13.64 3.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -165.26 -36.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.091 -1.005 . . . . 0.0 110.142 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.631 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -63.54 -68.22 0.36 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.043 -1.035 . . . . 0.0 108.719 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -28.67 -48.05 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.144 0.497 . . . . 0.0 110.542 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -54.12 -63.2 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.117 -0.99 . . . . 0.0 108.701 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.0 m-30 -69.82 -34.08 73.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.613 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -45.97 -38.51 8.22 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -95.07 -11.41 28.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.233 -1.157 . . . . 0.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -104.6 -52.14 2.94 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 109.841 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.652 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.2 p-90 -50.18 -42.77 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.495 -0.753 . . . . 0.0 109.435 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -54.3 -51.22 50.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -57.87 -14.03 15.22 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 23.7 mm-40 -92.92 -61.57 1.56 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -1.118 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.579 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 4.3 mt -74.51 -49.92 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.44 0.638 . . . . 0.0 110.071 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.555 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 1.5 ppp? -64.14 -15.74 60.4 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.615 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 61.7 t30 -106.78 -30.14 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.361 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 19' ' ' GLU . 67.6 m . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tt -174.95 162.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.164 . . . . 0.0 109.739 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.6 -8.91 3.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.513 ' O ' ' N ' ' B' ' 8' ' ' SER . 0.2 OUTLIER -129.18 -39.36 1.54 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 19.2 m-85 -59.44 -23.12 62.41 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.654 -0.654 . . . . 0.0 109.244 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.502 ' N ' HD21 ' B' ' 6' ' ' LEU . 0.8 OUTLIER -113.34 -4.89 13.6 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.569 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -134.92 1.19 2.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.939 -1.1 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.513 ' N ' ' O ' ' B' ' 4' ' ' LYS . 14.5 m -141.9 -38.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -67.2 -63.31 1.09 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 108.952 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' B' ' 9' ' ' ALA . 6.9 ptmt -33.31 -48.72 0.25 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.435 ' N ' ' CG ' ' B' ' 10' ' ' LYS . 23.6 mmtt -56.0 -61.15 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.103 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' B' ' 16' ' ' TRP . 1.7 m-85 -67.27 -27.03 66.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.29 -43.47 34.13 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -22.34 25.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -1.036 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.67 -49.54 5.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.068 . . . . 0.0 109.971 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.653 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -61.09 -45.95 92.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 109.364 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.3 OUTLIER -63.57 -48.75 85.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.595 -1.316 . . . . 0.0 108.62 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.1 -13.38 14.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.557 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -90.63 -67.85 0.82 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.568 -0.96 . . . . 0.0 108.642 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.532 ' CD1' HD13 ' A' ' 6' ' ' LEU . 60.8 mt -75.88 -40.06 38.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.984 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.53 ' CB ' ' O ' ' B' ' 17' ' ' VAL . 0.6 OUTLIER -63.06 -19.85 64.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.328 -0.857 . . . . 0.0 109.93 -179.377 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' B' ' 19' ' ' GLU . 3.4 p-10 -106.88 -19.05 13.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.947 -1.096 . . . . 0.0 109.588 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' B' ' 22' ' ' ASN . 46.4 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.66 70.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -1.191 . . . . 0.0 109.74 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.441 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -120.93 3.02 11.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -133.39 -35.01 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -1.052 . . . . 0.0 108.538 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.604 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 1.9 m-85 -75.04 -20.5 59.54 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.47 -0.769 . . . . 0.0 109.367 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.516 HD23 ' N ' ' A' ' 6' ' ' LEU . 1.1 mm? -114.65 6.91 15.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.162 -0.962 . . . . 0.0 109.908 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.441 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 3.4 m-70 -147.84 14.78 1.06 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.334 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -159.95 -39.42 0.05 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.418 -0.801 . . . . 0.0 109.125 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.623 ' HB2' ' CG ' ' B' ' 16' ' ' TRP . . . -61.75 -65.77 0.64 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 108.951 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -25.0 -54.15 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.19 0.519 . . . . 0.0 110.763 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -49.03 -64.26 0.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 108.816 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -71.44 -36.99 71.44 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.588 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.86 -33.4 2.55 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.552 ' HE2' ' CH2' ' B' ' 16' ' ' TRP . 2.2 mptp? -95.11 -22.92 17.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -1.098 . . . . 0.0 109.841 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.76 -47.95 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 0.0 109.758 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.667 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.968 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.575 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.3 OUTLIER -67.61 -49.86 66.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.732 -1.23 . . . . 0.0 108.29 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.75 -14.79 10.44 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.4 tp10 -88.58 -71.61 0.58 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.557 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 67.4 mt -70.4 -48.18 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.551 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.528 ' CB ' ' O ' ' A' ' 17' ' ' VAL . 2.8 tmm? -52.41 -20.5 2.87 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.349 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -86.31 -34.89 20.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.669 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 mt 62.67 63.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -1.155 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -141.54 22.09 2.54 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 -47.54 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.667 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 20.6 m-85 -62.07 -17.78 58.59 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.542 HD12 ' CD1' ' A' ' 20' ' ' ILE . 1.0 OUTLIER -109.45 -2.27 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.055 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.36 19.11 3.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.688 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' SER . . . . . 0.517 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.5 OUTLIER -167.27 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 110.063 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.616 ' HB2' ' CG ' ' A' ' 16' ' ' TRP . . . -66.82 -62.53 1.39 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.991 -1.068 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -35.05 -47.19 0.36 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.134 0.492 . . . . 0.0 109.979 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -51.74 -56.12 15.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.105 -0.997 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 7.7 m-85 -68.83 -30.96 69.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.606 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -44.6 -44.35 8.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -87.29 -19.21 28.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -1.021 . . . . 0.0 109.922 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -98.93 -0.06 42.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.623 ' CG ' ' HB2' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -119.21 -47.37 2.47 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.283 -0.886 . . . . 0.0 108.611 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -63.79 -41.49 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' B' ' 22' ' ' ASN . . . -65.56 -6.02 26.51 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 3.1 mm-40 -105.94 -68.52 0.87 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.208 -1.172 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.593 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 25.5 mt -64.29 -52.29 57.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.617 0.723 . . . . 0.0 109.904 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.554 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -47.94 -23.11 0.7 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.504 -0.747 . . . . 0.0 109.86 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' B' ' 18' ' ' GLY . 6.0 p30 -132.27 26.38 4.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.303 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' B' ' 20' ' ' ILE . 34.6 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.453 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -163.44 63.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.272 -1.134 . . . . 0.0 109.271 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.65 22.9 0.63 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' O ' ' N ' ' A' ' 8' ' ' SER . 0.0 OUTLIER -134.12 -43.81 0.79 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.567 -0.961 . . . . 0.0 108.517 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 8.5 m-85 -67.54 -20.41 65.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.648 ' CD1' ' N ' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -100.42 -1.4 35.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.409 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 16.3 m-70 -136.84 -30.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 110.124 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 4' ' ' LYS . 1.1 t -106.12 -32.87 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.025 . . . . 0.0 109.636 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.611 ' CB ' ' HA ' ' A' ' 5' ' ' TYR . . . -76.24 -59.42 2.77 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.182 -0.948 . . . . 0.0 109.16 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.489 ' HD3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -40.4 -35.25 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.541 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' HE2' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -61.51 -64.17 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -66.82 -34.04 76.93 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.616 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -42.4 -37.82 2.65 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -21.01 20.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.404 -1.057 . . . . 0.0 110.287 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -95.15 -52.93 3.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.044 -1.035 . . . . 0.0 110.277 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TRP . . . . . 0.714 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.4 p-90 -51.31 -42.63 61.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.551 -0.718 . . . . 0.0 109.87 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.8 OUTLIER -56.25 -51.0 68.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 108.923 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.03 -14.26 16.94 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 35.2 mm-40 -90.01 -63.93 1.21 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.261 -1.141 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.581 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 18.8 mt -74.6 -49.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.582 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.74 -11.22 53.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.723 -0.611 . . . . 0.0 110.334 -178.803 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 9.2 t30 -110.04 -27.26 9.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.075 . . . . 0.0 109.481 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.03 110.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -1.184 . . . . 0.0 109.585 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.86 -19.59 1.01 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -114.29 -19.48 11.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.949 -1.324 . . . . 0.0 108.815 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.714 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 3.9 m-85 -79.58 -25.0 41.66 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.468 -0.77 . . . . 0.0 109.774 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' LEU . . . . . 0.547 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 1.1 mm? -111.26 12.84 21.72 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.014 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' HIS . . . . . 0.547 ' CG ' ' C ' ' B' ' 6' ' ' LEU . 4.5 m-70 -152.66 16.95 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.133 -0.98 . . . . 0.0 109.45 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -165.6 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.216 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ALA . . . . . 0.613 ' CB ' ' HA ' ' B' ' 5' ' ' TYR . . . -61.98 -65.84 0.63 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.087 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LYS . . . . . 0.532 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -31.73 -44.41 0.08 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.709 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -64.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 108.994 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -70.68 -37.75 73.68 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.619 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.07 -36.63 2.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -97.72 -13.36 21.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -1.141 . . . . 0.0 109.983 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.44 -49.87 3.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.0 109.639 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TRP . . . . . 0.636 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -51.72 -43.94 63.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.793 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.634 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -58.21 -48.89 83.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.067 -1.021 . . . . 0.0 108.894 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.32 -13.63 16.54 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 3.9 mm-40 -93.9 -65.43 0.99 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.509 -0.995 . . . . 0.0 108.651 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.573 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 5.4 mt -69.38 -50.36 52.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.504 0.668 . . . . 0.0 109.548 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' MET . . . . . 0.514 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.1 OUTLIER -57.02 -15.45 5.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.799 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' B' ' 18' ' ' GLY . 0.2 OUTLIER -103.02 -46.75 4.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.233 179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' B' ' 22' ' ' ASN . 1.8 t . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.397 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.56 ' HA2' ' CE1' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -118.23 -20.08 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.23 -1.159 . . . . 0.0 109.473 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.945 ' C ' HD23 ' A' ' 6' ' ' LEU . 1.2 m-85 -88.34 -24.94 22.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.126 -0.984 . . . . 0.0 109.761 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.046 HD22 HG13 ' B' ' 20' ' ' ILE . 4.0 mt -118.03 15.87 14.18 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 108.878 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.39 13.48 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.39 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.287 -0.883 . . . . 0.0 109.408 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.76 -62.76 1.44 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.245 -0.909 . . . . 0.0 109.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -37.57 -54.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.784 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 10' ' ' LYS . 19.1 mmtt -44.39 -67.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.1 m-85 -59.31 -33.95 71.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.06 -34.89 3.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.09 -25.49 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -1.017 . . . . 0.0 109.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.68 -47.61 6.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.114 -0.992 . . . . 0.0 110.093 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.72 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -59.04 -43.98 91.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 109.534 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -63.8 -49.71 80.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.453 -1.405 . . . . 0.0 108.696 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.92 -13.27 18.35 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.8 tp10 -89.47 -68.1 0.8 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 HD22 ' B' ' 6' ' ' LEU . 63.8 mt -75.22 -45.54 41.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.743 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.5 tmm? -59.81 -22.44 62.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 32.2 t30 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.583 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -146.36 -41.37 0.2 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.72 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 10.1 m-85 -67.85 -15.65 63.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.713 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -112.16 -11.74 13.74 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.439 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -129.02 -11.12 4.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.882 -1.136 . . . . 0.0 110.225 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 -31.09 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.856 -1.152 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -77.16 -61.91 1.83 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 108.969 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -40.58 -51.97 2.9 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.232 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -50.23 -64.74 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.935 -1.103 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' B' ' 16' ' ' TRP . 4.9 m-30 -64.12 -34.05 77.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 109.155 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.622 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -42.32 -38.26 2.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -17.67 24.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.7 -45.23 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.908 -1.12 . . . . 0.0 110.531 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -54.9 -43.76 73.54 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.127 -0.983 . . . . 0.0 109.578 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.4 OUTLIER -59.73 -52.92 55.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.093 -1.004 . . . . 0.0 108.634 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.8 -18.21 8.01 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.723 ' HB2' HD21 ' A' ' 6' ' ' LEU . 4.3 mm-40 -87.06 -65.64 0.99 Allowed 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.382 -1.069 . . . . 0.0 108.332 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 1.046 HG13 HD22 ' A' ' 6' ' ' LEU . 10.7 mt -73.04 -49.92 35.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.775 0.798 . . . . 0.0 109.295 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.72 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 O-C-N 121.812 -0.555 . . . . 0.0 109.864 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.87 -41.34 0.06 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.897 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -82.31 -10.9 58.92 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.874 HD22 ' N ' ' A' ' 6' ' ' LEU . 1.6 mm? -114.06 10.06 17.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.663 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.557 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 19.1 m-70 -131.14 -31.64 1.66 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.112 -0.992 . . . . 0.0 110.076 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -127.6 -29.96 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 109.853 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.897 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -51.19 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.077 -1.015 . . . . 0.0 108.841 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' ALA . 18.7 tttp -29.16 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.637 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' SER . 13.6 mttm -55.66 -64.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.958 -1.089 . . . . 0.0 108.335 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 1.4 m-85 -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -51.06 -44.67 51.16 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 15.0 mmmt -85.75 -13.31 48.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -100.21 -49.41 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.67 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.8 p-90 -60.42 -41.68 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 110.36 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -58.24 -53.11 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.076 . . . . 0.0 108.846 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -54.27 -17.25 7.66 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 8.6 mm-40 -88.95 -65.42 1.02 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.374 -1.074 . . . . 0.0 108.438 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.59 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 15.7 mt -71.7 -49.64 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.548 0.69 . . . . 0.0 109.677 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.56 ' HG3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -56.58 -20.32 20.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 109.812 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 8.0 t30 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.628 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.61 -46.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -1.051 . . . . 0.0 108.278 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 4.5 m-85 -70.02 -15.31 62.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.522 -0.736 . . . . 0.0 109.066 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.556 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.5 OUTLIER -113.71 6.56 16.88 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.11 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.575 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 11.9 m-70 -141.29 12.91 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 109.908 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.439 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.0 OUTLIER -164.89 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -62.11 -63.52 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.015 . . . . 0.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' ALA . 6.2 ttpt -33.24 -44.72 0.13 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.237 0.541 . . . . 0.0 110.048 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -52.1 -66.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' B' ' 16' ' ' TRP . 1.4 m-85 -69.33 -17.93 63.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.585 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -57.06 -39.8 90.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -88.21 -37.85 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.054 . . . . 0.0 109.968 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.92 -47.21 21.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.692 ' CB ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.8 -50.57 70.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -68.57 -43.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.744 -1.222 . . . . 0.0 108.049 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.8 -13.47 18.59 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' B' ' 19' ' ' GLU . 1.1 tp10 -91.89 -68.82 0.77 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.783 HD11 HD12 ' A' ' 6' ' ' LEU . 60.0 mt -73.15 -47.2 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.888 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.865 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.9 tmm? . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.499 ' HA2' ' CE1' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 tttt 175.84 -48.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 4.5 m-85 -69.92 -14.29 62.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -114.31 -1.48 13.55 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.499 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 2.3 m80 -134.84 10.37 3.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.879 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.534 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.9 t -157.98 -37.66 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.06 -64.19 0.98 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.046 -1.034 . . . . 0.0 108.942 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -30.24 -51.97 0.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.105 0.479 . . . . 0.0 110.284 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -47.14 -67.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 8' ' ' SER . 3.2 m-85 -66.16 -39.16 89.56 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.81 -32.76 2.29 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -96.67 -15.54 21.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -103.38 -48.09 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.906 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.738 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.3 p-90 -58.72 -43.04 90.01 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -57.18 -52.0 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.042 -1.036 . . . . 0.0 109.1 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.14 -15.51 10.83 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.9 mm-40 -91.32 -64.11 1.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.378 -1.072 . . . . 0.0 108.71 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 6.1 mt -71.48 -50.57 39.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.509 0.671 . . . . 0.0 110.132 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -63.27 -19.67 64.78 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.4 -0.812 . . . . 0.0 109.742 -178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 35.6 t30 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 109.5 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.567 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 3' ' ' GLY . 25.1 tttt 175.31 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 1.9 m-85 -76.01 -17.09 59.83 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.548 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.7 OUTLIER -112.69 14.34 20.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.434 -0.791 . . . . 0.0 109.779 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.567 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 18.2 m-70 -142.36 -32.97 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.208 -0.932 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -119.25 -32.38 4.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.757 -1.214 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.1 -67.18 0.43 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.048 -1.033 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 8.6 ptmm? -30.85 -39.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.075 -0.391 . . . . 0.0 110.877 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.522 ' N ' ' HG3' ' B' ' 10' ' ' LYS . 0.4 OUTLIER -62.01 -62.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.788 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 1.1 m-85 -71.16 -31.85 68.2 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -46.94 -38.01 9.99 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -91.52 -20.35 21.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -1.128 . . . . 0.0 110.339 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -92.17 -56.8 2.92 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.689 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -49.83 -46.02 50.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.774 -0.579 . . . . 0.0 109.657 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.616 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -56.93 -53.39 43.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.244 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -54.13 -17.72 8.14 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 9.3 mm-40 -88.33 -66.42 0.92 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -1.209 . . . . 0.0 108.301 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.6 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 29.8 mt -71.22 -49.21 49.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.617 0.723 . . . . 0.0 109.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.601 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.747 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.714 ' HA2' ' CE1' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.22 -41.56 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.532 -0.981 . . . . 0.0 108.472 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.814 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 14.4 m-85 -69.9 -24.84 63.46 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.389 0.614 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.627 ' HB2' ' CE1' ' A' ' 7' ' ' HIS . 0.8 OUTLIER -111.73 20.55 16.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.346 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.714 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 0.6 OUTLIER -151.61 -28.42 0.18 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.341 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.6 -2.59 4.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.698 -1.251 . . . . 0.0 110.266 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -92.24 -63.8 1.19 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.066 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 1.4 ttmt -36.46 -46.15 0.54 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.487 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -51.03 -65.46 0.55 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 0.0 109.177 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.5 m-85 -70.96 -22.8 62.16 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -53.48 -35.21 50.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.31 -27.47 18.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -1.018 . . . . 0.0 110.274 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.89 -47.73 7.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.954 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.2 OUTLIER -59.76 -43.44 94.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.253 -0.905 . . . . 0.0 109.451 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.758 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -68.36 -52.28 38.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.714 -1.241 . . . . 0.0 108.388 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -53.31 -16.74 5.07 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 4.5 tp10 -86.65 -72.44 0.5 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.023 HD11 HD13 ' B' ' 6' ' ' LEU . 79.5 mt -70.47 -47.45 65.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.685 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.758 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -51.93 -22.43 3.86 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.683 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 4.9 m120 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.09 -1.007 . . . . 0.0 109.489 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' GLY . . . . . 0.587 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' B' ' 5' ' ' TYR . 0.3 OUTLIER -137.1 -45.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -1.082 . . . . 0.0 108.445 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 8.2 m-85 -72.15 -14.58 61.86 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -111.58 5.43 19.39 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.159 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.587 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 16.8 m-70 -138.29 15.31 2.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.088 -1.008 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.94 -35.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.018 -1.051 . . . . 0.0 109.829 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.635 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.46 -64.06 0.97 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.239 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.527 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -33.57 -48.47 0.26 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.172 0.51 . . . . 0.0 110.035 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -53.48 -64.33 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' B' ' 15' ' ' ALA . 3.6 m-85 -63.95 -30.11 71.22 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.304 -0.872 . . . . 0.0 108.735 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.598 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.04 -40.61 28.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -97.36 -11.75 23.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.482 -1.01 . . . . 0.0 109.454 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' B' ' 12' ' ' PHE . . . -102.88 -5.48 23.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.928 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.814 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -109.9 -44.27 3.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.232 -0.917 . . . . 0.0 109.285 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.5 OUTLIER -59.02 -52.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.428 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.72 -18.39 8.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 30.8 mm-40 -88.72 -65.28 1.03 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.382 -1.069 . . . . 0.0 108.647 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.586 HD11 HD13 ' A' ' 6' ' ' LEU . 7.0 mt -70.56 -50.91 41.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.436 0.636 . . . . 0.0 110.191 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 109.898 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -147.26 -41.78 0.18 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 18.7 m-85 -68.51 -22.69 64.51 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.852 HD13 HD11 ' B' ' 20' ' ' ILE . 2.0 mm? -108.43 7.06 26.8 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 14.4 m-70 -140.31 12.51 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.031 -1.043 . . . . 0.0 109.75 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.85 -36.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -60.4 -70.89 0.15 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.151 -1.019 . . . . 0.0 108.71 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.577 ' HD3' ' CD1' ' B' ' 20' ' ' ILE . 5.3 mtpt -30.78 -53.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.078 0.466 . . . . 0.0 110.401 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' LYS . 8.5 mttt -45.69 -65.83 0.49 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' TRP . 10.4 m-85 -66.23 -30.22 70.62 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.65 -38.4 5.5 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -94.46 -18.49 21.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.426 -1.043 . . . . 0.0 109.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' GLU . . . -102.43 2.64 36.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.086 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.748 ' CZ2' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -121.23 -47.03 2.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG23 ' CZ2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -60.84 -50.79 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.78 -15.8 14.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -91.32 -65.75 0.99 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.434 -1.039 . . . . 0.0 108.529 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 39.0 mt -73.1 -47.82 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.499 0.666 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.536 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -59.06 -18.47 35.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.73 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 27.4 m-20 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.22 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -10.88 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 108.995 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 2.0 m-85 -94.58 -17.74 22.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.374 -0.829 . . . . 0.0 109.256 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.624 ' HB2' ' CE1' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -114.9 16.68 17.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.094 -1.004 . . . . 0.0 109.529 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.624 ' CE1' ' HB2' ' B' ' 6' ' ' LEU . 0.2 OUTLIER -152.81 -30.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 1.6 m -120.28 -5.18 9.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.805 -1.184 . . . . 0.0 109.798 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.623 ' CB ' ' HA ' ' B' ' 5' ' ' TYR . . . -96.41 -58.75 1.98 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.15 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -39.64 -34.78 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.815 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.5 ' HG2' ' HD2' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -59.04 -66.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.253 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.541 ' O ' ' N ' ' B' ' 16' ' ' TRP . 11.6 m-85 -67.3 -20.85 65.68 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -51.45 -37.15 39.72 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -91.04 -41.26 11.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.605 -0.938 . . . . 0.0 109.988 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -45.32 29.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.02 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.695 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.73 -49.98 72.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.724 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.3 OUTLIER -64.79 -52.77 50.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.679 -1.263 . . . . 0.0 109.399 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.574 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -52.26 -18.11 4.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.527 ' HG3' ' N ' ' B' ' 20' ' ' ILE . 5.5 tp10 -87.21 -69.29 0.69 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.637 -0.919 . . . . 0.0 108.545 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 6' ' ' LEU . 6.0 mt -68.5 -49.47 65.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.584 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.724 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 110.034 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 -41.89 0.27 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.748 ' C ' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -65.34 -20.82 66.56 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.53 -0.732 . . . . 0.0 109.035 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.914 HD13 HD11 ' B' ' 20' ' ' ILE . 3.5 mm? -107.66 5.25 26.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.888 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 9.1 m-70 -136.92 9.88 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.128 -0.982 . . . . 0.0 110.166 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.23 -36.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.062 -1.024 . . . . 0.0 109.823 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -63.16 -67.55 0.42 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.537 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.603 ' HD2' HD11 ' B' ' 20' ' ' ILE . 14.0 mtpt -30.03 -56.74 0.18 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -44.29 -66.27 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 109.074 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.1 m-85 -66.21 -33.06 74.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.563 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.6 -32.36 1.98 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -26.88 13.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -1.143 . . . . 0.0 109.672 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 -46.11 8.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 0.0 109.873 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -60.12 -44.63 94.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.783 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -63.17 -50.28 79.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.501 -1.374 . . . . 0.0 109.014 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.51 -15.18 10.88 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -88.39 -69.08 0.72 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HD13 ' B' ' 6' ' ' LEU . 68.2 mt -71.92 -48.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.565 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.783 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -54.94 -19.06 5.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.392 -0.817 . . . . 0.0 109.417 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 20.1 t-20 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.117 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -44.68 0.67 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.421 -1.046 . . . . 0.0 108.605 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 36.8 m-85 -64.16 -17.79 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.379 -0.826 . . . . 0.0 109.448 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 20' ' ' ILE . 1.3 mm? -110.37 -9.81 14.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 110.48 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -128.03 12.19 6.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.964 -1.085 . . . . 0.0 110.158 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.7 t -158.24 -37.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.028 -1.045 . . . . 0.0 110.108 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' TRP . . . -66.18 -65.02 0.73 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -38.57 -47.88 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.633 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 11' ' ' LYS . 1.3 mptm? -45.89 -68.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.8 m-85 -64.07 -29.82 70.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.89 -36.71 3.82 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -90.74 -29.96 17.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.94 -48.09 7.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.058 -1.026 . . . . 0.0 110.007 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -61.92 -44.71 96.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.706 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -66.75 -49.13 77.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.586 -1.321 . . . . 0.0 108.627 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -57.17 -15.43 14.76 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.672 ' HG2' HD21 ' A' ' 6' ' ' LEU . 3.5 tp10 -86.82 -72.5 0.5 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.914 HD11 HD13 ' A' ' 6' ' ' LEU . 85.3 mt -70.11 -48.19 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.924 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.706 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -39.69 0.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 23.6 m-85 -66.8 -21.89 66.03 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.523 -0.736 . . . . 0.0 109.344 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 20' ' ' ILE . 2.1 mm? -107.43 2.41 24.27 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -137.18 18.02 2.98 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 109.685 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -169.49 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 109.953 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.81 -66.75 0.49 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.064 -1.022 . . . . 0.0 108.88 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -30.31 -52.12 0.15 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.058 0.456 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' LYS . 4.0 mmtp -44.76 -67.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' A' ' 16' ' ' TRP . 3.3 m-85 -67.29 -33.54 75.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.63 -30.58 1.51 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.73 -34.29 10.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -1.103 . . . . 0.0 110.087 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' B' ' 5' ' ' TYR . . . -86.5 -38.18 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.895 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.1 OUTLIER -71.02 -45.81 63.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 109.797 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -65.73 -51.06 66.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.45 -1.406 . . . . 0.0 108.803 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -55.92 -15.45 9.89 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -87.22 -71.32 0.57 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HD13 ' B' ' 6' ' ' LEU . 79.0 mt -71.42 -47.67 57.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.71 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.6 tmm? -55.26 -19.51 8.54 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.91 -39.35 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.342 -1.093 . . . . 0.0 108.125 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 30.1 m-85 -68.93 -25.79 64.75 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.44 -0.787 . . . . 0.0 109.494 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 20' ' ' ILE . 3.2 mm? -103.95 9.64 36.58 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.013 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' B' ' 6' ' ' LEU . 20.4 m-70 -138.47 13.34 2.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.955 -1.091 . . . . 0.0 110.156 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.469 ' HG ' ' HE2' ' B' ' 12' ' ' PHE . 0.3 OUTLIER -171.16 -34.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 110.186 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.637 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.31 -66.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.107 -0.996 . . . . 0.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.594 ' HD2' HD13 ' A' ' 20' ' ' ILE . 8.3 mtpt -31.3 -50.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.142 0.496 . . . . 0.0 110.292 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.18 -64.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 108.833 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.1 m-85 -68.42 -22.23 64.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.568 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -56.25 -35.22 64.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -90.96 -29.03 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.091 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.24 -46.08 8.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.856 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.847 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.98 -47.69 82.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.347 -0.846 . . . . 0.0 109.407 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.847 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -68.94 -48.17 71.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.769 -1.207 . . . . 0.0 108.026 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.437 ' N ' HG12 ' B' ' 17' ' ' VAL . . . -55.83 -16.85 13.38 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.831 -2.107 . . . . 0.0 107.831 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -87.69 -71.9 0.55 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 6' ' ' LEU . 49.9 mt -70.73 -48.13 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.708 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.669 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.5 tmm? . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 -40.64 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 35.1 m-85 -63.98 -20.68 66.07 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.895 HD13 HD11 ' B' ' 20' ' ' ILE . 1.4 mm? -109.65 2.38 20.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.161 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -137.21 13.64 3.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -165.26 -36.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.091 -1.005 . . . . 0.0 110.142 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.54 -68.22 0.36 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.043 -1.035 . . . . 0.0 108.719 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -28.67 -48.05 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.144 0.497 . . . . 0.0 110.542 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -54.12 -63.2 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.117 -0.99 . . . . 0.0 108.701 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.0 m-30 -69.82 -34.08 73.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -45.97 -38.51 8.22 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -95.07 -11.41 28.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.233 -1.157 . . . . 0.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -104.6 -52.14 2.94 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 109.841 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.677 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.2 p-90 -50.18 -42.77 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.495 -0.753 . . . . 0.0 109.435 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -54.3 -51.22 50.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -57.87 -14.03 15.22 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 23.7 mm-40 -92.92 -61.57 1.56 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -1.118 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.602 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 4.3 mt -74.51 -49.92 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.44 0.638 . . . . 0.0 110.071 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.555 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 1.5 ppp? -64.14 -15.74 60.4 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.615 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 61.7 t30 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.361 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' B' ' 8' ' ' SER . 0.2 OUTLIER -129.18 -39.36 1.54 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 19.2 m-85 -59.44 -23.12 62.41 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.654 -0.654 . . . . 0.0 109.244 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.604 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.8 OUTLIER -113.34 -4.89 13.6 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.569 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -134.92 1.19 2.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.939 -1.1 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.475 ' N ' ' O ' ' B' ' 4' ' ' LYS . 14.5 m -141.9 -38.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -67.2 -63.31 1.09 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 108.952 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' B' ' 6' ' ' LEU . 6.9 ptmt -33.31 -48.72 0.25 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' B' ' 11' ' ' LYS . 23.6 mmtt -56.0 -61.15 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.103 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' B' ' 16' ' ' TRP . 1.7 m-85 -67.27 -27.03 66.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.29 -43.47 34.13 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -22.34 25.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -1.036 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.67 -49.54 5.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.068 . . . . 0.0 109.971 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -61.09 -45.95 92.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 109.364 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -63.57 -48.75 85.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.595 -1.316 . . . . 0.0 108.62 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.1 -13.38 14.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -90.63 -67.85 0.82 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.568 -0.96 . . . . 0.0 108.642 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.895 HD11 HD13 ' A' ' 6' ' ' LEU . 60.8 mt -75.88 -40.06 38.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.984 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.744 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.328 -0.857 . . . . 0.0 109.93 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -133.39 -35.01 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -1.052 . . . . 0.0 108.538 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -75.04 -20.5 59.54 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.47 -0.769 . . . . 0.0 109.367 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 5' ' ' TYR . 1.1 mm? -114.65 6.91 15.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.162 -0.962 . . . . 0.0 109.908 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.523 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 1.7 m80 -147.84 14.78 1.06 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.334 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -159.95 -39.42 0.05 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.418 -0.801 . . . . 0.0 109.125 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.75 -65.77 0.64 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 108.951 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -25.0 -54.15 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.19 0.519 . . . . 0.0 110.763 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -49.03 -64.26 0.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 108.816 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -71.44 -36.99 71.44 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.86 -33.4 2.55 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HE2' ' CH2' ' B' ' 16' ' ' TRP . 2.2 mptp? -95.11 -22.92 17.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -1.098 . . . . 0.0 109.841 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.76 -47.95 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 0.0 109.758 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.968 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.686 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -67.61 -49.86 66.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.732 -1.23 . . . . 0.0 108.29 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.75 -14.79 10.44 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.4 tp10 -88.58 -71.61 0.58 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.659 HG12 HD11 ' B' ' 6' ' ' LEU . 67.4 mt -70.4 -48.18 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.551 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.686 ' HB2' HG22 ' A' ' 17' ' ' VAL . 2.8 tmm? -52.41 -20.5 2.87 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.349 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 -47.54 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.71 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 20.6 m-85 -62.07 -17.78 58.59 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.659 HD11 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -109.45 -2.27 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.055 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.36 19.11 3.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.688 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' SER . . . . . 0.517 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.5 OUTLIER -167.27 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 110.063 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.605 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -66.82 -62.53 1.39 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.991 -1.068 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -35.05 -47.19 0.36 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.134 0.492 . . . . 0.0 109.979 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -51.74 -56.12 15.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.105 -0.997 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 7.7 m-85 -68.83 -30.96 69.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.604 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -44.6 -44.35 8.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -87.29 -19.21 28.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -1.021 . . . . 0.0 109.922 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -98.93 -0.06 42.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.698 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -119.21 -47.37 2.47 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.283 -0.886 . . . . 0.0 108.611 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.698 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -63.79 -41.49 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.42 ' C ' ' OE1' ' B' ' 19' ' ' GLU . . . -65.56 -6.02 26.51 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 3.1 mm-40 -105.94 -68.52 0.87 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.208 -1.172 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.613 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 25.5 mt -64.29 -52.29 57.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.617 0.723 . . . . 0.0 109.904 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 O-C-N 121.504 -0.747 . . . . 0.0 109.86 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -134.12 -43.81 0.79 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.567 -0.961 . . . . 0.0 108.517 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 8.5 m-85 -67.54 -20.41 65.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' B' ' 20' ' ' ILE . 0.5 OUTLIER -100.42 -1.4 35.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' HIS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 16.3 m-70 -136.84 -30.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 110.124 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' LYS . 1.1 t -106.12 -32.87 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.025 . . . . 0.0 109.636 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' CB ' ' HA ' ' A' ' 5' ' ' TYR . . . -76.24 -59.42 2.77 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.182 -0.948 . . . . 0.0 109.16 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HD3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -40.4 -35.25 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.541 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -61.51 -64.17 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -66.82 -34.04 76.93 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -42.4 -37.82 2.65 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -21.01 20.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.404 -1.057 . . . . 0.0 110.287 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -95.15 -52.93 3.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.044 -1.035 . . . . 0.0 110.277 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.4 p-90 -51.31 -42.63 61.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.551 -0.718 . . . . 0.0 109.87 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG22 ' CB ' ' A' ' 21' ' ' MET . 0.8 OUTLIER -56.25 -51.0 68.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 108.923 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.03 -14.26 16.94 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 35.2 mm-40 -90.01 -63.93 1.21 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.261 -1.141 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.599 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 18.8 mt -74.6 -49.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.748 ' CB ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.74 -11.22 53.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.723 -0.611 . . . . 0.0 110.334 -178.803 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 9.2 t30 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.075 . . . . 0.0 109.481 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -114.29 -19.48 11.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.949 -1.324 . . . . 0.0 108.815 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.757 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 3.9 m-85 -79.58 -25.0 41.66 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.468 -0.77 . . . . 0.0 109.774 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' LEU . . . . . 0.547 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 1.1 mm? -111.26 12.84 21.72 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.014 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' HIS . . . . . 0.547 ' CG ' ' C ' ' B' ' 6' ' ' LEU . 2.3 m80 -152.66 16.95 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.133 -0.98 . . . . 0.0 109.45 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -165.6 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.216 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.98 -65.84 0.63 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.087 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -31.73 -44.41 0.08 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.709 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -64.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 108.994 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -70.68 -37.75 73.68 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLY . . . . . 0.611 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.07 -36.63 2.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -97.72 -13.36 21.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -1.141 . . . . 0.0 109.983 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.44 -49.87 3.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.0 109.639 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' TRP . . . . . 0.673 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -51.72 -43.94 63.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.793 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.634 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -58.21 -48.89 83.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.067 -1.021 . . . . 0.0 108.894 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.32 -13.63 16.54 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 3.9 mm-40 -93.9 -65.43 0.99 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.509 -0.995 . . . . 0.0 108.651 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 6' ' ' LEU . 5.4 mt -69.38 -50.36 52.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.504 0.668 . . . . 0.0 109.548 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' MET . . . . . 0.628 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.799 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 4.6 mt 64.19 131.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -1.19 . . . . 0.0 109.61 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.56 ' HA2' ' CE1' ' A' ' 7' ' ' HIS . . . 146.55 -14.28 1.6 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -118.23 -20.08 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.23 -1.159 . . . . 0.0 109.473 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.945 ' C ' HD23 ' A' ' 6' ' ' LEU . 1.2 m-85 -88.34 -24.94 22.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.126 -0.984 . . . . 0.0 109.761 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.046 HD22 HG13 ' B' ' 20' ' ' ILE . 4.0 mt -118.03 15.87 14.18 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 108.878 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.56 ' CE1' ' HB2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -149.39 13.48 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.39 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.287 -0.883 . . . . 0.0 109.408 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.76 -62.76 1.44 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.245 -0.909 . . . . 0.0 109.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -37.57 -54.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.784 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 10' ' ' LYS . 19.1 mmtt -44.39 -67.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.1 m-85 -59.31 -33.95 71.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.06 -34.89 3.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.09 -25.49 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -1.017 . . . . 0.0 109.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.68 -47.61 6.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.114 -0.992 . . . . 0.0 110.093 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.72 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -59.04 -43.98 91.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 109.534 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -63.8 -49.71 80.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.453 -1.405 . . . . 0.0 108.696 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.92 -13.27 18.35 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.8 tp10 -89.47 -68.1 0.8 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 HD22 ' B' ' 6' ' ' LEU . 63.8 mt -75.22 -45.54 41.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.743 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.5 tmm? -59.81 -22.44 62.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 32.2 t30 -80.84 -33.01 34.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' B' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.489 HG22 ' O ' ' B' ' 2' ' ' ILE . 1.9 mp 62.44 91.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -1.092 . . . . 0.0 109.743 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.14 24.45 0.32 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -146.36 -41.37 0.2 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.72 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 10.1 m-85 -67.85 -15.65 63.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.713 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -112.16 -11.74 13.74 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.439 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -129.02 -11.12 4.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.882 -1.136 . . . . 0.0 110.225 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 -31.09 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.856 -1.152 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -77.16 -61.91 1.83 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 108.969 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -40.58 -51.97 2.9 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.232 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -50.23 -64.74 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.935 -1.103 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' B' ' 16' ' ' TRP . 4.9 m-30 -64.12 -34.05 77.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 109.155 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.622 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -42.32 -38.26 2.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -17.67 24.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.7 -45.23 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.908 -1.12 . . . . 0.0 110.531 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -54.9 -43.76 73.54 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.127 -0.983 . . . . 0.0 109.578 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.4 OUTLIER -59.73 -52.92 55.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.093 -1.004 . . . . 0.0 108.634 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.8 -18.21 8.01 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.723 ' HB2' HD21 ' A' ' 6' ' ' LEU . 4.3 mm-40 -87.06 -65.64 0.99 Allowed 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.382 -1.069 . . . . 0.0 108.332 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 1.046 HG13 HD22 ' A' ' 6' ' ' LEU . 10.7 mt -73.04 -49.92 35.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.775 0.798 . . . . 0.0 109.295 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.72 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -57.76 -23.96 54.72 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.812 -0.555 . . . . 0.0 109.864 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' B' ' 18' ' ' GLY . 13.5 t30 -101.93 -34.5 9.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.481 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mt -136.14 140.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -1.113 . . . . 0.0 109.312 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . 118.42 31.69 1.48 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.87 -41.34 0.06 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.897 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -82.31 -10.9 58.92 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.874 HD22 ' N ' ' A' ' 6' ' ' LEU . 1.6 mm? -114.06 10.06 17.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.663 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.557 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 19.1 m-70 -131.14 -31.64 1.66 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.112 -0.992 . . . . 0.0 110.076 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -127.6 -29.96 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 109.853 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.897 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -51.19 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.077 -1.015 . . . . 0.0 108.841 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' ALA . 18.7 tttp -29.16 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.637 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' SER . 13.6 mttm -55.66 -64.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.958 -1.089 . . . . 0.0 108.335 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 1.4 m-85 -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -51.06 -44.67 51.16 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 15.0 mmmt -85.75 -13.31 48.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -100.21 -49.41 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.67 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.8 p-90 -60.42 -41.68 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 110.36 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -58.24 -53.11 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.076 . . . . 0.0 108.846 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -54.27 -17.25 7.66 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.585 ' OE1' HG21 ' B' ' 2' ' ' ILE . 8.6 mm-40 -88.95 -65.42 1.02 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.374 -1.074 . . . . 0.0 108.438 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.59 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 15.7 mt -71.7 -49.64 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.548 0.69 . . . . 0.0 109.677 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.56 ' HG3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -56.58 -20.32 20.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 109.812 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 8.0 t30 -102.25 -36.86 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.628 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.496 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.585 HG21 ' OE1' ' A' ' 19' ' ' GLU . 5.6 pt -111.56 92.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.296 -1.12 . . . . 0.0 109.5 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . -126.43 25.07 5.47 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.61 -46.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -1.051 . . . . 0.0 108.278 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 4.5 m-85 -70.02 -15.31 62.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.522 -0.736 . . . . 0.0 109.066 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.556 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.5 OUTLIER -113.71 6.56 16.88 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.11 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.575 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 11.9 m-70 -141.29 12.91 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 109.908 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.439 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.0 OUTLIER -164.89 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -62.11 -63.52 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.015 . . . . 0.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' ALA . 6.2 ttpt -33.24 -44.72 0.13 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.237 0.541 . . . . 0.0 110.048 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -52.1 -66.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' B' ' 16' ' ' TRP . 1.4 m-85 -69.33 -17.93 63.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.585 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -57.06 -39.8 90.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -88.21 -37.85 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.054 . . . . 0.0 109.968 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.92 -47.21 21.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.692 ' CB ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.8 -50.57 70.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -68.57 -43.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.744 -1.222 . . . . 0.0 108.049 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' B' ' 22' ' ' ASN . . . -58.8 -13.47 18.59 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.537 ' OE1' ' CA ' ' B' ' 19' ' ' GLU . 1.1 tp10 -91.89 -68.82 0.77 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.783 HD11 HD12 ' A' ' 6' ' ' LEU . 60.0 mt -73.15 -47.2 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.888 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.865 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.9 tmm? -53.97 -24.67 17.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER -72.22 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 109.452 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.57 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.71 83.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -1.101 . . . . 0.0 109.54 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.499 ' HA2' ' CE1' ' A' ' 7' ' ' HIS . . . -137.18 55.8 0.69 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 tttt 175.84 -48.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 4.5 m-85 -69.92 -14.29 62.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -114.31 -1.48 13.55 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.499 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 2.3 m80 -134.84 10.37 3.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.879 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.534 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.9 t -157.98 -37.66 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.06 -64.19 0.98 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.046 -1.034 . . . . 0.0 108.942 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -30.24 -51.97 0.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.105 0.479 . . . . 0.0 110.284 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -47.14 -67.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 8' ' ' SER . 3.2 m-85 -66.16 -39.16 89.56 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.81 -32.76 2.29 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -96.67 -15.54 21.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -103.38 -48.09 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.906 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.738 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.3 p-90 -58.72 -43.04 90.01 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -57.18 -52.0 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.042 -1.036 . . . . 0.0 109.1 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.14 -15.51 10.83 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.9 mm-40 -91.32 -64.11 1.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.378 -1.072 . . . . 0.0 108.71 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 6.1 mt -71.48 -50.57 39.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.509 0.671 . . . . 0.0 110.132 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -63.27 -19.67 64.78 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.4 -0.812 . . . . 0.0 109.742 -178.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 35.6 t30 -109.19 9.23 26.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 109.5 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 26.8 t . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.586 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.618 HG21 ' HG ' ' B' ' 6' ' ' LEU . 2.5 mp -95.45 85.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 109.627 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.567 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . -142.14 59.5 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 3' ' ' GLY . 25.1 tttt 175.31 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 1.9 m-85 -76.01 -17.09 59.83 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.618 ' HG ' HG21 ' B' ' 2' ' ' ILE . 0.7 OUTLIER -112.69 14.34 20.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.434 -0.791 . . . . 0.0 109.779 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.567 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 18.2 m-70 -142.36 -32.97 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.208 -0.932 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -119.25 -32.38 4.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.757 -1.214 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.1 -67.18 0.43 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.048 -1.033 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 8.6 ptmm? -30.85 -39.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.075 -0.391 . . . . 0.0 110.877 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.522 ' N ' ' HG3' ' B' ' 10' ' ' LYS . 0.4 OUTLIER -62.01 -62.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.788 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 1.1 m-85 -71.16 -31.85 68.2 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -46.94 -38.01 9.99 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -91.52 -20.35 21.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -1.128 . . . . 0.0 110.339 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -92.17 -56.8 2.92 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.689 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -49.83 -46.02 50.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.774 -0.579 . . . . 0.0 109.657 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.616 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -56.93 -53.39 43.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.244 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -54.13 -17.72 8.14 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 9.3 mm-40 -88.33 -66.42 0.92 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -1.209 . . . . 0.0 108.301 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.6 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 29.8 mt -71.22 -49.21 49.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.617 0.723 . . . . 0.0 109.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.601 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.5 OUTLIER -55.13 -19.23 7.04 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.747 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 26.8 t30 -102.84 -21.89 13.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.214 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.354 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.706 HD11 ' HG ' ' A' ' 6' ' ' LEU . 3.9 tt -84.53 106.27 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.714 ' HA2' ' CE1' ' A' ' 7' ' ' HIS . . . -150.61 17.76 0.99 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.22 -41.56 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.532 -0.981 . . . . 0.0 108.472 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.814 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 14.4 m-85 -69.9 -24.84 63.46 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.389 0.614 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.706 ' HG ' HD11 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -111.73 20.55 16.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.346 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.714 ' CE1' ' HA2' ' A' ' 3' ' ' GLY . 0.6 OUTLIER -151.61 -28.42 0.18 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.341 -178.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.6 -2.59 4.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.698 -1.251 . . . . 0.0 110.266 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -92.24 -63.8 1.19 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.066 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 1.4 ttmt -36.46 -46.15 0.54 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.487 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -51.03 -65.46 0.55 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 0.0 109.177 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.5 m-85 -70.96 -22.8 62.16 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -53.48 -35.21 50.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.31 -27.47 18.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -1.018 . . . . 0.0 110.274 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.89 -47.73 7.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.954 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.2 OUTLIER -59.76 -43.44 94.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.253 -0.905 . . . . 0.0 109.451 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.758 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -68.36 -52.28 38.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.714 -1.241 . . . . 0.0 108.388 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -53.31 -16.74 5.07 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 4.5 tp10 -86.65 -72.44 0.5 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.023 HD11 HD13 ' B' ' 6' ' ' LEU . 79.5 mt -70.47 -47.45 65.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.685 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.758 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -51.93 -22.43 3.86 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.683 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 4.9 m120 -100.49 -23.8 14.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.09 -1.007 . . . . 0.0 109.489 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.519 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.7 HD12 ' N ' ' B' ' 2' ' ' ILE . 2.0 mp -113.51 174.66 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 109.386 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' GLY . . . . . 0.615 ' H ' HG22 ' B' ' 2' ' ' ILE . . . 111.98 11.08 17.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' B' ' 5' ' ' TYR . 0.3 OUTLIER -137.1 -45.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -1.082 . . . . 0.0 108.445 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 8.2 m-85 -72.15 -14.58 61.86 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -111.58 5.43 19.39 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.159 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.587 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 16.8 m-70 -138.29 15.31 2.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.088 -1.008 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.94 -35.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.018 -1.051 . . . . 0.0 109.829 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.635 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.46 -64.06 0.97 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.239 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.527 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -33.57 -48.47 0.26 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.172 0.51 . . . . 0.0 110.035 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -53.48 -64.33 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' B' ' 15' ' ' ALA . 3.6 m-85 -63.95 -30.11 71.22 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.304 -0.872 . . . . 0.0 108.735 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.598 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.04 -40.61 28.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -97.36 -11.75 23.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.482 -1.01 . . . . 0.0 109.454 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' B' ' 12' ' ' PHE . . . -102.88 -5.48 23.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.928 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.814 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -109.9 -44.27 3.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.232 -0.917 . . . . 0.0 109.285 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.5 OUTLIER -59.02 -52.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.428 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.72 -18.39 8.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 30.8 mm-40 -88.72 -65.28 1.03 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.382 -1.069 . . . . 0.0 108.647 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.586 HD11 HD13 ' A' ' 6' ' ' LEU . 7.0 mt -70.56 -50.91 41.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.436 0.636 . . . . 0.0 110.191 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -59.69 -25.69 64.97 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 109.898 -178.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.477 ' N ' ' HG3' ' B' ' 21' ' ' MET . 35.1 t30 -96.74 -46.36 6.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.411 ' OXT' ' O ' ' B' ' 22' ' ' ASN . 9.2 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.29 86.88 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -1.177 . . . . 0.0 109.442 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -154.83 27.87 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -147.26 -41.78 0.18 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 18.7 m-85 -68.51 -22.69 64.51 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.852 HD13 HD11 ' B' ' 20' ' ' ILE . 2.0 mm? -108.43 7.06 26.8 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 14.4 m-70 -140.31 12.51 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.031 -1.043 . . . . 0.0 109.75 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.85 -36.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -60.4 -70.89 0.15 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.151 -1.019 . . . . 0.0 108.71 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.577 ' HD3' ' CD1' ' B' ' 20' ' ' ILE . 5.3 mtpt -30.78 -53.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.078 0.466 . . . . 0.0 110.401 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' LYS . 8.5 mttt -45.69 -65.83 0.49 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' TRP . 10.4 m-85 -66.23 -30.22 70.62 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.65 -38.4 5.5 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -94.46 -18.49 21.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.426 -1.043 . . . . 0.0 109.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' GLU . . . -102.43 2.64 36.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.086 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.748 ' CZ2' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -121.23 -47.03 2.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG23 ' CZ2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -60.84 -50.79 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.78 -15.8 14.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -91.32 -65.75 0.99 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.434 -1.039 . . . . 0.0 108.529 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 39.0 mt -73.1 -47.82 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.499 0.666 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.536 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -59.06 -18.47 35.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.73 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 27.4 m-20 -103.55 -34.47 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.455 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.11 73.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -1.189 . . . . 0.0 109.662 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.14 -17.92 2.93 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -10.88 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 108.995 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 2.0 m-85 -94.58 -17.74 22.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.374 -0.829 . . . . 0.0 109.256 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.58 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.6 OUTLIER -114.9 16.68 17.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.094 -1.004 . . . . 0.0 109.529 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -152.81 -30.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 1.6 m -120.28 -5.18 9.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.805 -1.184 . . . . 0.0 109.798 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.623 ' CB ' ' HA ' ' B' ' 5' ' ' TYR . . . -96.41 -58.75 1.98 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.15 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -39.64 -34.78 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.815 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.5 ' HG2' ' HD2' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -59.04 -66.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.253 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.541 ' O ' ' N ' ' B' ' 16' ' ' TRP . 11.6 m-85 -67.3 -20.85 65.68 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -51.45 -37.15 39.72 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -91.04 -41.26 11.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.605 -0.938 . . . . 0.0 109.988 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -45.32 29.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.02 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.695 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.73 -49.98 72.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.724 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.3 OUTLIER -64.79 -52.77 50.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.679 -1.263 . . . . 0.0 109.399 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.574 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -52.26 -18.11 4.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.527 ' HG3' ' N ' ' B' ' 20' ' ' ILE . 5.5 tp10 -87.21 -69.29 0.69 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.637 -0.919 . . . . 0.0 108.545 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 6' ' ' LEU . 6.0 mt -68.5 -49.47 65.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.584 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.724 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER -61.43 -19.03 61.51 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 110.034 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 1.8 m-20 -66.41 -58.32 5.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.976 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.535 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.776 ' O ' HG22 ' A' ' 2' ' ' ILE . 54.7 mt 56.83 41.54 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -1.141 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.45 1.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 -41.89 0.27 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' C ' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -65.34 -20.82 66.56 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.53 -0.732 . . . . 0.0 109.035 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.914 HD13 HD11 ' B' ' 20' ' ' ILE . 3.5 mm? -107.66 5.25 26.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.888 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 9.1 m-70 -136.92 9.88 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.128 -0.982 . . . . 0.0 110.166 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.23 -36.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.062 -1.024 . . . . 0.0 109.823 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -63.16 -67.55 0.42 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.537 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.603 ' HD2' HD11 ' B' ' 20' ' ' ILE . 14.0 mtpt -30.03 -56.74 0.18 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -44.29 -66.27 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 109.074 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.1 m-85 -66.21 -33.06 74.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.563 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.6 -32.36 1.98 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -26.88 13.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -1.143 . . . . 0.0 109.672 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 -46.11 8.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 0.0 109.873 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -60.12 -44.63 94.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.783 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -63.17 -50.28 79.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.501 -1.374 . . . . 0.0 109.014 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.51 -15.18 10.88 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -88.39 -69.08 0.72 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HD13 ' B' ' 6' ' ' LEU . 68.2 mt -71.92 -48.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.565 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.783 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -54.94 -19.06 5.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.392 -0.817 . . . . 0.0 109.417 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 20.1 t-20 -80.82 -35.85 32.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.117 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.331 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.422 ' C ' HD12 ' B' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.545 HD12 ' N ' ' B' ' 2' ' ' ILE . 5.3 mp 51.66 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 109.53 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.57 18.26 1.0 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -44.68 0.67 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.421 -1.046 . . . . 0.0 108.605 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 36.8 m-85 -64.16 -17.79 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.379 -0.826 . . . . 0.0 109.448 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 20' ' ' ILE . 1.3 mm? -110.37 -9.81 14.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 110.48 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -128.03 12.19 6.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.964 -1.085 . . . . 0.0 110.158 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.7 t -158.24 -37.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.028 -1.045 . . . . 0.0 110.108 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' TRP . . . -66.18 -65.02 0.73 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -38.57 -47.88 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.633 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 11' ' ' LYS . 1.3 mptm? -45.89 -68.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.8 m-85 -64.07 -29.82 70.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.89 -36.71 3.82 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -90.74 -29.96 17.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.94 -48.09 7.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.058 -1.026 . . . . 0.0 110.007 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -61.92 -44.71 96.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.706 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -66.75 -49.13 77.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.586 -1.321 . . . . 0.0 108.627 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -57.17 -15.43 14.76 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.672 ' HG2' HD21 ' A' ' 6' ' ' LEU . 3.5 tp10 -86.82 -72.5 0.5 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.914 HD11 HD13 ' A' ' 6' ' ' LEU . 85.3 mt -70.11 -48.19 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.924 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.706 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -55.26 -24.49 28.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 -179.329 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 44.5 t30 -83.54 -30.91 26.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.375 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.9 pt -79.85 115.44 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -1.151 . . . . 0.0 109.318 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.3 11.88 3.54 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -39.69 0.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 23.6 m-85 -66.8 -21.89 66.03 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.523 -0.736 . . . . 0.0 109.344 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 20' ' ' ILE . 2.1 mm? -107.43 2.41 24.27 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -137.18 18.02 2.98 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 109.685 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -169.49 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 109.953 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.81 -66.75 0.49 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.064 -1.022 . . . . 0.0 108.88 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -30.31 -52.12 0.15 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.058 0.456 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' LYS . 4.0 mmtp -44.76 -67.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' A' ' 16' ' ' TRP . 3.3 m-85 -67.29 -33.54 75.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.63 -30.58 1.51 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.73 -34.29 10.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -1.103 . . . . 0.0 110.087 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' B' ' 5' ' ' TYR . . . -86.5 -38.18 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.895 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.1 OUTLIER -71.02 -45.81 63.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 109.797 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -65.73 -51.06 66.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.45 -1.406 . . . . 0.0 108.803 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -55.92 -15.45 9.89 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -87.22 -71.32 0.57 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HD13 ' B' ' 6' ' ' LEU . 79.0 mt -71.42 -47.67 57.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.71 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.6 tmm? -55.26 -19.51 8.54 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -78.68 -46.25 19.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 1.8 pt -143.97 64.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.185 -1.186 . . . . 0.0 109.757 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.69 9.66 6.43 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.91 -39.35 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.342 -1.093 . . . . 0.0 108.125 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 30.1 m-85 -68.93 -25.79 64.75 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.44 -0.787 . . . . 0.0 109.494 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 20' ' ' ILE . 3.2 mm? -103.95 9.64 36.58 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.013 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' B' ' 6' ' ' LEU . 20.4 m-70 -138.47 13.34 2.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.955 -1.091 . . . . 0.0 110.156 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.469 ' HG ' ' HE2' ' B' ' 12' ' ' PHE . 0.3 OUTLIER -171.16 -34.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 110.186 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.637 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.31 -66.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.107 -0.996 . . . . 0.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.594 ' HD2' HD13 ' A' ' 20' ' ' ILE . 8.3 mtpt -31.3 -50.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.142 0.496 . . . . 0.0 110.292 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.18 -64.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 108.833 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.1 m-85 -68.42 -22.23 64.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.568 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -56.25 -35.22 64.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -90.96 -29.03 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.091 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.24 -46.08 8.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.856 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.847 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.98 -47.69 82.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.347 -0.846 . . . . 0.0 109.407 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.847 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -68.94 -48.17 71.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.769 -1.207 . . . . 0.0 108.026 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.437 ' N ' HG12 ' B' ' 17' ' ' VAL . . . -55.83 -16.85 13.38 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.831 -2.107 . . . . 0.0 107.831 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -87.69 -71.9 0.55 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 6' ' ' LEU . 49.9 mt -70.73 -48.13 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.708 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.669 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.5 tmm? -56.95 -19.25 16.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.28 -60.25 2.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.108 -0.995 . . . . 0.0 109.287 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.501 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.3 mm 59.4 75.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -1.129 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.52 13.71 2.02 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 -40.64 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 35.1 m-85 -63.98 -20.68 66.07 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.895 HD13 HD11 ' B' ' 20' ' ' ILE . 1.4 mm? -109.65 2.38 20.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.161 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -137.21 13.64 3.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -165.26 -36.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.091 -1.005 . . . . 0.0 110.142 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.54 -68.22 0.36 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.043 -1.035 . . . . 0.0 108.719 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -28.67 -48.05 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.144 0.497 . . . . 0.0 110.542 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -54.12 -63.2 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.117 -0.99 . . . . 0.0 108.701 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.0 m-30 -69.82 -34.08 73.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -45.97 -38.51 8.22 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -95.07 -11.41 28.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.233 -1.157 . . . . 0.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -104.6 -52.14 2.94 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 109.841 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.677 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.2 p-90 -50.18 -42.77 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.495 -0.753 . . . . 0.0 109.435 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -54.3 -51.22 50.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -57.87 -14.03 15.22 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 23.7 mm-40 -92.92 -61.57 1.56 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -1.118 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.602 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 4.3 mt -74.51 -49.92 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.44 0.638 . . . . 0.0 110.071 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.555 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 1.5 ppp? -64.14 -15.74 60.4 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.615 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 61.7 t30 -106.78 -30.14 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.361 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 19' ' ' GLU . 67.6 m . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tt -174.95 162.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.164 . . . . 0.0 109.739 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.6 -8.91 3.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' B' ' 8' ' ' SER . 0.2 OUTLIER -129.18 -39.36 1.54 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 19.2 m-85 -59.44 -23.12 62.41 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.654 -0.654 . . . . 0.0 109.244 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.604 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.8 OUTLIER -113.34 -4.89 13.6 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.569 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -134.92 1.19 2.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.939 -1.1 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.475 ' N ' ' O ' ' B' ' 4' ' ' LYS . 14.5 m -141.9 -38.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -67.2 -63.31 1.09 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 108.952 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' B' ' 6' ' ' LEU . 6.9 ptmt -33.31 -48.72 0.25 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' B' ' 11' ' ' LYS . 23.6 mmtt -56.0 -61.15 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.103 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' B' ' 16' ' ' TRP . 1.7 m-85 -67.27 -27.03 66.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.29 -43.47 34.13 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -22.34 25.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -1.036 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.67 -49.54 5.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.068 . . . . 0.0 109.971 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -61.09 -45.95 92.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 109.364 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -63.57 -48.75 85.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.595 -1.316 . . . . 0.0 108.62 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.1 -13.38 14.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -90.63 -67.85 0.82 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.568 -0.96 . . . . 0.0 108.642 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.895 HD11 HD13 ' A' ' 6' ' ' LEU . 60.8 mt -75.88 -40.06 38.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.984 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.744 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.6 OUTLIER -63.06 -19.85 64.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.328 -0.857 . . . . 0.0 109.93 -179.377 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' B' ' 19' ' ' GLU . 3.4 p-10 -106.88 -19.05 13.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.947 -1.096 . . . . 0.0 109.588 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' B' ' 22' ' ' ASN . 46.4 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.66 70.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -1.191 . . . . 0.0 109.74 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -120.93 3.02 11.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -133.39 -35.01 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -1.052 . . . . 0.0 108.538 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -75.04 -20.5 59.54 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.47 -0.769 . . . . 0.0 109.367 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 5' ' ' TYR . 1.1 mm? -114.65 6.91 15.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.162 -0.962 . . . . 0.0 109.908 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 3.4 m-70 -147.84 14.78 1.06 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.334 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -159.95 -39.42 0.05 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.418 -0.801 . . . . 0.0 109.125 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.75 -65.77 0.64 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 108.951 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -25.0 -54.15 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.19 0.519 . . . . 0.0 110.763 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -49.03 -64.26 0.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 108.816 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.595 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -71.44 -36.99 71.44 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.86 -33.4 2.55 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HE2' ' CH2' ' B' ' 16' ' ' TRP . 2.2 mptp? -95.11 -22.92 17.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -1.098 . . . . 0.0 109.841 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.76 -47.95 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 0.0 109.758 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.968 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.686 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -67.61 -49.86 66.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.732 -1.23 . . . . 0.0 108.29 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.75 -14.79 10.44 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.4 tp10 -88.58 -71.61 0.58 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.659 HG12 HD11 ' B' ' 6' ' ' LEU . 67.4 mt -70.4 -48.18 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.551 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.686 ' HB2' HG22 ' A' ' 17' ' ' VAL . 2.8 tmm? -52.41 -20.5 2.87 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.349 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -86.31 -34.89 20.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.669 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 mt 62.67 63.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -1.155 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -141.54 22.09 2.54 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 -47.54 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.71 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 20.6 m-85 -62.07 -17.78 58.59 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.659 HD11 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -109.45 -2.27 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.055 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.36 19.11 3.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.688 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' SER . . . . . 0.517 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.5 OUTLIER -167.27 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 110.063 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.605 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -66.82 -62.53 1.39 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.991 -1.068 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -35.05 -47.19 0.36 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.134 0.492 . . . . 0.0 109.979 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -51.74 -56.12 15.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.105 -0.997 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 7.7 m-85 -68.83 -30.96 69.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.604 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -44.6 -44.35 8.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -87.29 -19.21 28.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -1.021 . . . . 0.0 109.922 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -98.93 -0.06 42.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.698 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -119.21 -47.37 2.47 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.283 -0.886 . . . . 0.0 108.611 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.698 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -63.79 -41.49 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' B' ' 22' ' ' ASN . . . -65.56 -6.02 26.51 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 3.1 mm-40 -105.94 -68.52 0.87 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.208 -1.172 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.613 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 25.5 mt -64.29 -52.29 57.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.617 0.723 . . . . 0.0 109.904 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -47.94 -23.11 0.7 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.504 -0.747 . . . . 0.0 109.86 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' B' ' 18' ' ' GLY . 6.0 p30 -132.27 26.38 4.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.303 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' B' ' 20' ' ' ILE . 34.6 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -163.44 63.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.272 -1.134 . . . . 0.0 109.271 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.65 22.9 0.63 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -134.12 -43.81 0.79 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.567 -0.961 . . . . 0.0 108.517 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 8.5 m-85 -67.54 -20.41 65.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' B' ' 20' ' ' ILE . 0.5 OUTLIER -100.42 -1.4 35.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 16.3 m-70 -136.84 -30.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 110.124 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' LYS . 1.1 t -106.12 -32.87 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.025 . . . . 0.0 109.636 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' CB ' ' HA ' ' A' ' 5' ' ' TYR . . . -76.24 -59.42 2.77 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.182 -0.948 . . . . 0.0 109.16 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HD3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -40.4 -35.25 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.541 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -61.51 -64.17 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' CD1' ' N ' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -66.82 -34.04 76.93 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -42.4 -37.82 2.65 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -21.01 20.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.404 -1.057 . . . . 0.0 110.287 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -95.15 -52.93 3.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.044 -1.035 . . . . 0.0 110.277 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.4 p-90 -51.31 -42.63 61.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.551 -0.718 . . . . 0.0 109.87 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG22 ' CB ' ' A' ' 21' ' ' MET . 0.8 OUTLIER -56.25 -51.0 68.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 108.923 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.03 -14.26 16.94 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 35.2 mm-40 -90.01 -63.93 1.21 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.261 -1.141 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.599 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 18.8 mt -74.6 -49.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.748 ' CB ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.74 -11.22 53.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.723 -0.611 . . . . 0.0 110.334 -178.803 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 9.2 t30 -110.04 -27.26 9.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.075 . . . . 0.0 109.481 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ILE . . . . . 0.426 HD13 ' HG ' ' B' ' 6' ' ' LEU . 1.0 OUTLIER -139.03 110.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -1.184 . . . . 0.0 109.585 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.86 -19.59 1.01 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -114.29 -19.48 11.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.949 -1.324 . . . . 0.0 108.815 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.757 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 3.9 m-85 -79.58 -25.0 41.66 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.468 -0.77 . . . . 0.0 109.774 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' LEU . . . . . 0.547 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 1.1 mm? -111.26 12.84 21.72 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.014 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' HIS . . . . . 0.547 ' CG ' ' C ' ' B' ' 6' ' ' LEU . 2.3 m80 -152.66 16.95 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.133 -0.98 . . . . 0.0 109.45 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -165.6 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.216 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.98 -65.84 0.63 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.087 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -31.73 -44.41 0.08 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.709 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -64.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 108.994 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -70.68 -37.75 73.68 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.611 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.07 -36.63 2.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -97.72 -13.36 21.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -1.141 . . . . 0.0 109.983 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.44 -49.87 3.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.0 109.639 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TRP . . . . . 0.673 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -51.72 -43.94 63.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.793 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.634 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -58.21 -48.89 83.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.067 -1.021 . . . . 0.0 108.894 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.32 -13.63 16.54 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 3.9 mm-40 -93.9 -65.43 0.99 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.509 -0.995 . . . . 0.0 108.651 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 6' ' ' LEU . 5.4 mt -69.38 -50.36 52.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.504 0.668 . . . . 0.0 109.548 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' MET . . . . . 0.628 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER -57.02 -15.45 5.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.799 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' B' ' 18' ' ' GLY . 0.2 OUTLIER -103.02 -46.75 4.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.233 179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' B' ' 22' ' ' ASN . 1.8 t . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.397 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.569 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -118.23 -20.08 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.23 -1.159 . . . . 0.0 109.473 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.945 ' C ' HD23 ' A' ' 6' ' ' LEU . 1.2 m-85 -88.34 -24.94 22.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.126 -0.984 . . . . 0.0 109.761 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.046 HD22 HG13 ' B' ' 20' ' ' ILE . 4.0 mt -118.03 15.87 14.18 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 108.878 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.601 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 0.1 OUTLIER -149.39 13.48 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.39 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.287 -0.883 . . . . 0.0 109.408 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.76 -62.76 1.44 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.245 -0.909 . . . . 0.0 109.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -37.57 -54.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.784 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 10' ' ' LYS . 19.1 mmtt -44.39 -67.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.1 m-85 -59.31 -33.95 71.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.06 -34.89 3.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.09 -25.49 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -1.017 . . . . 0.0 109.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.68 -47.61 6.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.114 -0.992 . . . . 0.0 110.093 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.72 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -59.04 -43.98 91.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 109.534 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -63.8 -49.71 80.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.453 -1.405 . . . . 0.0 108.696 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.92 -13.27 18.35 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.8 tp10 -89.47 -68.1 0.8 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 HD22 ' B' ' 6' ' ' LEU . 63.8 mt -75.22 -45.54 41.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.743 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.5 tmm? -59.81 -22.44 62.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 32.2 t30 . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.583 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -146.36 -41.37 0.2 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.72 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 10.1 m-85 -67.85 -15.65 63.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.713 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -112.16 -11.74 13.74 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.439 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -129.02 -11.12 4.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.882 -1.136 . . . . 0.0 110.225 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 -31.09 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.856 -1.152 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -77.16 -61.91 1.83 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 108.969 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -40.58 -51.97 2.9 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.232 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -50.23 -64.74 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.935 -1.103 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' B' ' 16' ' ' TRP . 4.9 m-30 -64.12 -34.05 77.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 109.155 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.622 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -42.32 -38.26 2.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -17.67 24.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.7 -45.23 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.908 -1.12 . . . . 0.0 110.531 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -54.9 -43.76 73.54 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.127 -0.983 . . . . 0.0 109.578 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.4 OUTLIER -59.73 -52.92 55.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.093 -1.004 . . . . 0.0 108.634 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.8 -18.21 8.01 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.723 ' HB2' HD21 ' A' ' 6' ' ' LEU . 4.3 mm-40 -87.06 -65.64 0.99 Allowed 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.382 -1.069 . . . . 0.0 108.332 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 1.046 HG13 HD22 ' A' ' 6' ' ' LEU . 10.7 mt -73.04 -49.92 35.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.775 0.798 . . . . 0.0 109.295 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.72 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.642 0 O-C-N 121.812 -0.555 . . . . 0.0 109.864 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.87 -41.34 0.06 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.897 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -82.31 -10.9 58.92 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.874 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.6 mm? -114.06 10.06 17.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.663 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.557 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 19.1 m-70 -131.14 -31.64 1.66 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.112 -0.992 . . . . 0.0 110.076 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -127.6 -29.96 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 109.853 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.897 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -51.19 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.077 -1.015 . . . . 0.0 108.841 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' ALA . 18.7 tttp -29.16 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.637 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' SER . 13.6 mttm -55.66 -64.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.958 -1.089 . . . . 0.0 108.335 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 1.4 m-85 -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -51.06 -44.67 51.16 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 15.0 mmmt -85.75 -13.31 48.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -100.21 -49.41 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.67 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.8 p-90 -60.42 -41.68 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 110.36 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -58.24 -53.11 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.076 . . . . 0.0 108.846 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -54.27 -17.25 7.66 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 8.6 mm-40 -88.95 -65.42 1.02 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.374 -1.074 . . . . 0.0 108.438 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.59 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 15.7 mt -71.7 -49.64 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.548 0.69 . . . . 0.0 109.677 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.56 ' HG3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -56.58 -20.32 20.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 109.812 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 8.0 t30 . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.628 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.202 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.61 -46.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -1.051 . . . . 0.0 108.278 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 4.5 m-85 -70.02 -15.31 62.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.522 -0.736 . . . . 0.0 109.066 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.556 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.5 OUTLIER -113.71 6.56 16.88 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.11 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.575 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 11.9 m-70 -141.29 12.91 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 109.908 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.439 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.0 OUTLIER -164.89 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -62.11 -63.52 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.015 . . . . 0.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' ALA . 6.2 ttpt -33.24 -44.72 0.13 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.237 0.541 . . . . 0.0 110.048 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -52.1 -66.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' B' ' 16' ' ' TRP . 1.4 m-85 -69.33 -17.93 63.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.585 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -57.06 -39.8 90.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -88.21 -37.85 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.054 . . . . 0.0 109.968 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.92 -47.21 21.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.692 ' CB ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.8 -50.57 70.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -68.57 -43.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.744 -1.222 . . . . 0.0 108.049 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.433 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.8 -13.47 18.59 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.537 ' CA ' ' OE1' ' B' ' 19' ' ' GLU . 1.1 tp10 -91.89 -68.82 0.77 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.783 HD11 HD12 ' A' ' 6' ' ' LEU . 60.0 mt -73.15 -47.2 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.888 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.865 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.9 tmm? . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 tttt 175.84 -48.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 4.5 m-85 -69.92 -14.29 62.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -114.31 -1.48 13.55 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.492 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 7.1 m-70 -134.84 10.37 3.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.879 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.534 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.9 t -157.98 -37.66 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.06 -64.19 0.98 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.046 -1.034 . . . . 0.0 108.942 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -30.24 -51.97 0.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.105 0.479 . . . . 0.0 110.284 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -47.14 -67.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 8' ' ' SER . 3.2 m-85 -66.16 -39.16 89.56 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.81 -32.76 2.29 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -96.67 -15.54 21.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -103.38 -48.09 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.906 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.738 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.3 p-90 -58.72 -43.04 90.01 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -57.18 -52.0 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.042 -1.036 . . . . 0.0 109.1 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.14 -15.51 10.83 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.9 mm-40 -91.32 -64.11 1.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.378 -1.072 . . . . 0.0 108.71 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 6.1 mt -71.48 -50.57 39.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.509 0.671 . . . . 0.0 110.132 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -63.27 -19.67 64.78 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.4 -0.812 . . . . 0.0 109.742 -178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 35.6 t30 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 109.5 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.567 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.234 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 3' ' ' GLY . 25.1 tttt 175.31 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 1.9 m-85 -76.01 -17.09 59.83 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.548 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.7 OUTLIER -112.69 14.34 20.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.434 -0.791 . . . . 0.0 109.779 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.567 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 18.2 m-70 -142.36 -32.97 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.208 -0.932 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -119.25 -32.38 4.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.757 -1.214 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.1 -67.18 0.43 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.048 -1.033 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 8.6 ptmm? -30.85 -39.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.075 -0.391 . . . . 0.0 110.877 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.522 ' N ' ' HG3' ' B' ' 10' ' ' LYS . 0.4 OUTLIER -62.01 -62.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.788 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 1.1 m-85 -71.16 -31.85 68.2 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -46.94 -38.01 9.99 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -91.52 -20.35 21.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -1.128 . . . . 0.0 110.339 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -92.17 -56.8 2.92 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.689 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -49.83 -46.02 50.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.774 -0.579 . . . . 0.0 109.657 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.616 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -56.93 -53.39 43.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.244 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -54.13 -17.72 8.14 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 9.3 mm-40 -88.33 -66.42 0.92 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -1.209 . . . . 0.0 108.301 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.6 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 29.8 mt -71.22 -49.21 49.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.617 0.723 . . . . 0.0 109.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.601 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.747 -179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.518 ' HA2' ' NE2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.22 -41.56 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.532 -0.981 . . . . 0.0 108.472 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.814 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 14.4 m-85 -69.9 -24.84 63.46 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.389 0.614 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.586 HD13 HD11 ' B' ' 20' ' ' ILE . 0.8 OUTLIER -111.73 20.55 16.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.346 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.541 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 1.5 m-70 -151.61 -28.42 0.18 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.341 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.6 -2.59 4.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.698 -1.251 . . . . 0.0 110.266 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -92.24 -63.8 1.19 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.066 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 1.4 ttmt -36.46 -46.15 0.54 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.487 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -51.03 -65.46 0.55 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 0.0 109.177 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.5 m-85 -70.96 -22.8 62.16 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -53.48 -35.21 50.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.31 -27.47 18.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -1.018 . . . . 0.0 110.274 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.89 -47.73 7.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.954 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.2 OUTLIER -59.76 -43.44 94.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.253 -0.905 . . . . 0.0 109.451 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.758 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -68.36 -52.28 38.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.714 -1.241 . . . . 0.0 108.388 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -53.31 -16.74 5.07 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 4.5 tp10 -86.65 -72.44 0.5 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.023 HD11 HD13 ' B' ' 6' ' ' LEU . 79.5 mt -70.47 -47.45 65.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.685 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.758 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -51.93 -22.43 3.86 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.683 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 2.6 m-80 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.09 -1.007 . . . . 0.0 109.489 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . 0.587 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' B' ' 5' ' ' TYR . 0.3 OUTLIER -137.1 -45.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -1.082 . . . . 0.0 108.445 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 8.2 m-85 -72.15 -14.58 61.86 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -111.58 5.43 19.39 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.159 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.587 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 16.8 m-70 -138.29 15.31 2.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.088 -1.008 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.94 -35.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.018 -1.051 . . . . 0.0 109.829 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.635 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.46 -64.06 0.97 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.239 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.527 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -33.57 -48.47 0.26 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.172 0.51 . . . . 0.0 110.035 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -53.48 -64.33 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' B' ' 15' ' ' ALA . 3.6 m-85 -63.95 -30.11 71.22 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.304 -0.872 . . . . 0.0 108.735 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.598 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.04 -40.61 28.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -97.36 -11.75 23.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.482 -1.01 . . . . 0.0 109.454 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' B' ' 12' ' ' PHE . . . -102.88 -5.48 23.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.928 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.814 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -109.9 -44.27 3.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.232 -0.917 . . . . 0.0 109.285 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.5 OUTLIER -59.02 -52.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.428 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.72 -18.39 8.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 30.8 mm-40 -88.72 -65.28 1.03 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.382 -1.069 . . . . 0.0 108.647 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.586 HD11 HD13 ' A' ' 6' ' ' LEU . 7.0 mt -70.56 -50.91 41.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.436 0.636 . . . . 0.0 110.191 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 109.898 -178.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -147.26 -41.78 0.18 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 18.7 m-85 -68.51 -22.69 64.51 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.852 HD13 HD11 ' B' ' 20' ' ' ILE . 2.0 mm? -108.43 7.06 26.8 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 14.4 m-70 -140.31 12.51 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.031 -1.043 . . . . 0.0 109.75 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.85 -36.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -60.4 -70.89 0.15 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.151 -1.019 . . . . 0.0 108.71 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.577 ' HD3' ' CD1' ' B' ' 20' ' ' ILE . 5.3 mtpt -30.78 -53.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.078 0.466 . . . . 0.0 110.401 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' LYS . 8.5 mttt -45.69 -65.83 0.49 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' TRP . 10.4 m-85 -66.23 -30.22 70.62 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.594 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.65 -38.4 5.5 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -94.46 -18.49 21.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.426 -1.043 . . . . 0.0 109.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' GLU . . . -102.43 2.64 36.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.086 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.748 ' CZ2' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -121.23 -47.03 2.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG23 ' CZ2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -60.84 -50.79 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.78 -15.8 14.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -91.32 -65.75 0.99 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.434 -1.039 . . . . 0.0 108.529 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 39.0 mt -73.1 -47.82 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.499 0.666 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.536 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -59.06 -18.47 35.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.73 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 27.4 m-20 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.22 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.501 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -10.88 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 108.995 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 2.0 m-85 -94.58 -17.74 22.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.374 -0.829 . . . . 0.0 109.256 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.58 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.6 OUTLIER -114.9 16.68 17.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.094 -1.004 . . . . 0.0 109.529 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.538 ' CD2' ' N ' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -152.81 -30.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 1.6 m -120.28 -5.18 9.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.805 -1.184 . . . . 0.0 109.798 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.623 ' CB ' ' HA ' ' B' ' 5' ' ' TYR . . . -96.41 -58.75 1.98 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.15 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -39.64 -34.78 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.815 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.5 ' HG2' ' HD2' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -59.04 -66.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.253 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.541 ' O ' ' N ' ' B' ' 16' ' ' TRP . 11.6 m-85 -67.3 -20.85 65.68 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -51.45 -37.15 39.72 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -91.04 -41.26 11.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.605 -0.938 . . . . 0.0 109.988 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -45.32 29.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.02 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.695 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.73 -49.98 72.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.724 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.3 OUTLIER -64.79 -52.77 50.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.679 -1.263 . . . . 0.0 109.399 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.574 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -52.26 -18.11 4.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.527 ' HG3' ' N ' ' B' ' 20' ' ' ILE . 5.5 tp10 -87.21 -69.29 0.69 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.637 -0.919 . . . . 0.0 108.545 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 6' ' ' LEU . 6.0 mt -68.5 -49.47 65.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.584 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.724 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.298 -1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 110.034 -178.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 -41.89 0.27 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.748 ' C ' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -65.34 -20.82 66.56 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.53 -0.732 . . . . 0.0 109.035 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.914 HD13 HD11 ' B' ' 20' ' ' ILE . 3.5 mm? -107.66 5.25 26.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.888 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 9.1 m-70 -136.92 9.88 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.128 -0.982 . . . . 0.0 110.166 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.23 -36.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.062 -1.024 . . . . 0.0 109.823 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -63.16 -67.55 0.42 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.537 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.603 ' HD2' HD11 ' B' ' 20' ' ' ILE . 14.0 mtpt -30.03 -56.74 0.18 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -44.29 -66.27 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 109.074 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.1 m-85 -66.21 -33.06 74.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.563 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.6 -32.36 1.98 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -26.88 13.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -1.143 . . . . 0.0 109.672 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 -46.11 8.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 0.0 109.873 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -60.12 -44.63 94.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.783 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -63.17 -50.28 79.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.501 -1.374 . . . . 0.0 109.014 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.51 -15.18 10.88 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -88.39 -69.08 0.72 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HD13 ' B' ' 6' ' ' LEU . 68.2 mt -71.92 -48.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.565 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.783 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -54.94 -19.06 5.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.392 -0.817 . . . . 0.0 109.417 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 20.1 t-20 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.117 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -44.68 0.67 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.421 -1.046 . . . . 0.0 108.605 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 36.8 m-85 -64.16 -17.79 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.379 -0.826 . . . . 0.0 109.448 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 20' ' ' ILE . 1.3 mm? -110.37 -9.81 14.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 110.48 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.03 12.19 6.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.964 -1.085 . . . . 0.0 110.158 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.7 t -158.24 -37.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.028 -1.045 . . . . 0.0 110.108 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' TRP . . . -66.18 -65.02 0.73 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -38.57 -47.88 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.633 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 11' ' ' LYS . 1.3 mptm? -45.89 -68.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.8 m-85 -64.07 -29.82 70.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.89 -36.71 3.82 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -90.74 -29.96 17.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.94 -48.09 7.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.058 -1.026 . . . . 0.0 110.007 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -61.92 -44.71 96.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.706 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -66.75 -49.13 77.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.586 -1.321 . . . . 0.0 108.627 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -57.17 -15.43 14.76 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.672 ' HG2' HD21 ' A' ' 6' ' ' LEU . 3.5 tp10 -86.82 -72.5 0.5 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.914 HD11 HD13 ' A' ' 6' ' ' LEU . 85.3 mt -70.11 -48.19 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.924 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.706 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -39.69 0.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 23.6 m-85 -66.8 -21.89 66.03 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.523 -0.736 . . . . 0.0 109.344 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 20' ' ' ILE . 2.1 mm? -107.43 2.41 24.27 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -137.18 18.02 2.98 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 109.685 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -169.49 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 109.953 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.81 -66.75 0.49 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.064 -1.022 . . . . 0.0 108.88 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -30.31 -52.12 0.15 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.058 0.456 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' LYS . 4.0 mmtp -44.76 -67.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' A' ' 16' ' ' TRP . 3.3 m-85 -67.29 -33.54 75.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.63 -30.58 1.51 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.73 -34.29 10.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -1.103 . . . . 0.0 110.087 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' B' ' 5' ' ' TYR . . . -86.5 -38.18 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.895 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.1 OUTLIER -71.02 -45.81 63.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 109.797 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -65.73 -51.06 66.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.45 -1.406 . . . . 0.0 108.803 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -55.92 -15.45 9.89 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -87.22 -71.32 0.57 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HD13 ' B' ' 6' ' ' LEU . 79.0 mt -71.42 -47.67 57.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.71 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.6 tmm? -55.26 -19.51 8.54 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.91 -39.35 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.342 -1.093 . . . . 0.0 108.125 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 30.1 m-85 -68.93 -25.79 64.75 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.44 -0.787 . . . . 0.0 109.494 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 20' ' ' ILE . 3.2 mm? -103.95 9.64 36.58 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.013 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' B' ' 6' ' ' LEU . 20.4 m-70 -138.47 13.34 2.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.955 -1.091 . . . . 0.0 110.156 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.469 ' HG ' ' HE2' ' B' ' 12' ' ' PHE . 0.3 OUTLIER -171.16 -34.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 110.186 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.637 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.31 -66.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.107 -0.996 . . . . 0.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.594 ' HD2' HD13 ' A' ' 20' ' ' ILE . 8.3 mtpt -31.3 -50.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.142 0.496 . . . . 0.0 110.292 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.18 -64.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 108.833 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.1 m-85 -68.42 -22.23 64.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.568 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -56.25 -35.22 64.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -90.96 -29.03 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.091 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.24 -46.08 8.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.856 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.847 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.98 -47.69 82.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.347 -0.846 . . . . 0.0 109.407 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.847 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -68.94 -48.17 71.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.769 -1.207 . . . . 0.0 108.026 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.437 ' N ' HG12 ' B' ' 17' ' ' VAL . . . -55.83 -16.85 13.38 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.831 -2.107 . . . . 0.0 107.831 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -87.69 -71.9 0.55 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 6' ' ' LEU . 49.9 mt -70.73 -48.13 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.708 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.669 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.5 tmm? . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 -40.64 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 35.1 m-85 -63.98 -20.68 66.07 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.895 HD13 HD11 ' B' ' 20' ' ' ILE . 1.4 mm? -109.65 2.38 20.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.161 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -137.21 13.64 3.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -165.26 -36.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.091 -1.005 . . . . 0.0 110.142 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.54 -68.22 0.36 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.043 -1.035 . . . . 0.0 108.719 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -28.67 -48.05 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.144 0.497 . . . . 0.0 110.542 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -54.12 -63.2 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.117 -0.99 . . . . 0.0 108.701 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.0 m-30 -69.82 -34.08 73.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -45.97 -38.51 8.22 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -95.07 -11.41 28.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.233 -1.157 . . . . 0.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -104.6 -52.14 2.94 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 109.841 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.677 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.2 p-90 -50.18 -42.77 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.495 -0.753 . . . . 0.0 109.435 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -54.3 -51.22 50.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -57.87 -14.03 15.22 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 23.7 mm-40 -92.92 -61.57 1.56 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -1.118 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.602 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 4.3 mt -74.51 -49.92 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.44 0.638 . . . . 0.0 110.071 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.555 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 1.5 ppp? -64.14 -15.74 60.4 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.615 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 61.7 t30 . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.361 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.384 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' B' ' 8' ' ' SER . 0.2 OUTLIER -129.18 -39.36 1.54 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 19.2 m-85 -59.44 -23.12 62.41 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.654 -0.654 . . . . 0.0 109.244 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.604 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.8 OUTLIER -113.34 -4.89 13.6 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.569 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -134.92 1.19 2.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.939 -1.1 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.475 ' N ' ' O ' ' B' ' 4' ' ' LYS . 14.5 m -141.9 -38.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -67.2 -63.31 1.09 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 108.952 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' B' ' 6' ' ' LEU . 6.9 ptmt -33.31 -48.72 0.25 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' B' ' 11' ' ' LYS . 23.6 mmtt -56.0 -61.15 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.103 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' B' ' 16' ' ' TRP . 1.7 m-85 -67.27 -27.03 66.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.29 -43.47 34.13 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -22.34 25.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -1.036 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.67 -49.54 5.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.068 . . . . 0.0 109.971 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -61.09 -45.95 92.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 109.364 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -63.57 -48.75 85.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.595 -1.316 . . . . 0.0 108.62 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.1 -13.38 14.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -90.63 -67.85 0.82 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.568 -0.96 . . . . 0.0 108.642 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.895 HD11 HD13 ' A' ' 6' ' ' LEU . 60.8 mt -75.88 -40.06 38.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.984 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.744 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.484 0 O-C-N 121.328 -0.857 . . . . 0.0 109.93 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -133.39 -35.01 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -1.052 . . . . 0.0 108.538 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -75.04 -20.5 59.54 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.47 -0.769 . . . . 0.0 109.367 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 5' ' ' TYR . 1.1 mm? -114.65 6.91 15.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.162 -0.962 . . . . 0.0 109.908 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 3.4 m-70 -147.84 14.78 1.06 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.334 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -159.95 -39.42 0.05 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.418 -0.801 . . . . 0.0 109.125 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.75 -65.77 0.64 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 108.951 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -25.0 -54.15 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.19 0.519 . . . . 0.0 110.763 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -49.03 -64.26 0.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 108.816 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -71.44 -36.99 71.44 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.86 -33.4 2.55 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HE2' ' CH2' ' B' ' 16' ' ' TRP . 2.2 mptp? -95.11 -22.92 17.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -1.098 . . . . 0.0 109.841 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.76 -47.95 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 0.0 109.758 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.968 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.686 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -67.61 -49.86 66.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.732 -1.23 . . . . 0.0 108.29 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.75 -14.79 10.44 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.4 tp10 -88.58 -71.61 0.58 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.659 HG12 HD11 ' B' ' 6' ' ' LEU . 67.4 mt -70.4 -48.18 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.551 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.686 ' HB2' HG22 ' A' ' 17' ' ' VAL . 2.8 tmm? -52.41 -20.5 2.87 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.349 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 -47.54 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.71 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 20.6 m-85 -62.07 -17.78 58.59 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.659 HD11 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -109.45 -2.27 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.055 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.36 19.11 3.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.688 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . 0.517 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.5 OUTLIER -167.27 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 110.063 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.605 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -66.82 -62.53 1.39 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.991 -1.068 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -35.05 -47.19 0.36 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.134 0.492 . . . . 0.0 109.979 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -51.74 -56.12 15.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.105 -0.997 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 7.7 m-85 -68.83 -30.96 69.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.604 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -44.6 -44.35 8.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -87.29 -19.21 28.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -1.021 . . . . 0.0 109.922 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -98.93 -0.06 42.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.698 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -119.21 -47.37 2.47 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.283 -0.886 . . . . 0.0 108.611 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.698 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -63.79 -41.49 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.42 ' C ' ' OE1' ' B' ' 19' ' ' GLU . . . -65.56 -6.02 26.51 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 3.1 mm-40 -105.94 -68.52 0.87 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.208 -1.172 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.613 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 25.5 mt -64.29 -52.29 57.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.617 0.723 . . . . 0.0 109.904 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.3 -1.583 0 O-C-N 121.504 -0.747 . . . . 0.0 109.86 -179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -134.12 -43.81 0.79 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.567 -0.961 . . . . 0.0 108.517 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 8.5 m-85 -67.54 -20.41 65.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' B' ' 20' ' ' ILE . 0.5 OUTLIER -100.42 -1.4 35.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' HIS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 16.3 m-70 -136.84 -30.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 110.124 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' LYS . 1.1 t -106.12 -32.87 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.025 . . . . 0.0 109.636 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.63 ' CB ' ' HA ' ' A' ' 5' ' ' TYR . . . -76.24 -59.42 2.77 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.182 -0.948 . . . . 0.0 109.16 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HD3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -40.4 -35.25 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.541 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -61.51 -64.17 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -66.82 -34.04 76.93 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -42.4 -37.82 2.65 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -21.01 20.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.404 -1.057 . . . . 0.0 110.287 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -95.15 -52.93 3.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.044 -1.035 . . . . 0.0 110.277 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.4 p-90 -51.31 -42.63 61.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.551 -0.718 . . . . 0.0 109.87 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG22 ' CB ' ' A' ' 21' ' ' MET . 0.8 OUTLIER -56.25 -51.0 68.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 108.923 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.03 -14.26 16.94 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 35.2 mm-40 -90.01 -63.93 1.21 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.261 -1.141 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.599 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 18.8 mt -74.6 -49.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.748 ' CB ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.74 -11.22 53.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.723 -0.611 . . . . 0.0 110.334 -178.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 9.2 t30 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.075 . . . . 0.0 109.481 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -114.29 -19.48 11.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.949 -1.324 . . . . 0.0 108.815 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.757 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 3.9 m-85 -79.58 -25.0 41.66 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.468 -0.77 . . . . 0.0 109.774 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' LEU . . . . . 0.547 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 1.1 mm? -111.26 12.84 21.72 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.014 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' HIS . . . . . 0.547 ' CG ' ' C ' ' B' ' 6' ' ' LEU . 4.5 m-70 -152.66 16.95 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.133 -0.98 . . . . 0.0 109.45 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -165.6 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.216 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.98 -65.84 0.63 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.087 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -31.73 -44.41 0.08 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.709 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -64.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 108.994 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -70.68 -37.75 73.68 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . 0.611 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.07 -36.63 2.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -97.72 -13.36 21.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -1.141 . . . . 0.0 109.983 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.44 -49.87 3.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.0 109.639 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' TRP . . . . . 0.673 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -51.72 -43.94 63.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.793 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.634 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -58.21 -48.89 83.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.067 -1.021 . . . . 0.0 108.894 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.32 -13.63 16.54 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 3.9 mm-40 -93.9 -65.43 0.99 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.509 -0.995 . . . . 0.0 108.651 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 6' ' ' LEU . 5.4 mt -69.38 -50.36 52.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.504 0.668 . . . . 0.0 109.548 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' MET . . . . . 0.628 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.799 -179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' O ' ' HB ' ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.465 ' HB ' ' O ' ' A' ' 1' ' ' GLY . 4.6 mt 64.19 131.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.177 -1.19 . . . . 0.0 109.61 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . 146.55 -14.28 1.6 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.531 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -118.23 -20.08 8.73 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.23 -1.159 . . . . 0.0 109.473 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.945 ' C ' HD23 ' A' ' 6' ' ' LEU . 1.2 m-85 -88.34 -24.94 22.99 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.126 -0.984 . . . . 0.0 109.761 -179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.046 HD22 HG13 ' B' ' 20' ' ' ILE . 4.0 mt -118.03 15.87 14.18 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.025 -1.047 . . . . 0.0 108.878 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.601 ' N ' ' CD2' ' A' ' 7' ' ' HIS . 0.1 OUTLIER -149.39 13.48 0.85 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -165.39 -37.49 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.287 -0.883 . . . . 0.0 109.408 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.648 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.76 -62.76 1.44 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.245 -0.909 . . . . 0.0 109.059 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.558 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 0.6 OUTLIER -37.57 -54.66 1.15 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.784 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' C ' ' O ' ' A' ' 10' ' ' LYS . 19.1 mmtt -44.39 -67.41 0.28 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.562 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.1 m-85 -59.31 -33.95 71.71 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.06 -34.89 3.29 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.09 -25.49 16.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.471 -1.017 . . . . 0.0 109.92 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.68 -47.61 6.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.114 -0.992 . . . . 0.0 110.093 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.72 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -59.04 -43.98 91.73 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.259 -0.9 . . . . 0.0 109.534 -179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.743 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -63.8 -49.71 80.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 120.453 -1.405 . . . . 0.0 108.696 -179.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.558 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.92 -13.27 18.35 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 108.11 -1.996 . . . . 0.0 108.11 178.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.8 tp10 -89.47 -68.1 0.8 Allowed 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 HD22 ' B' ' 6' ' ' LEU . 63.8 mt -75.22 -45.54 41.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.644 -0.822 . . . . 0.0 109.461 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.743 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.5 tmm? -59.81 -22.44 62.22 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.369 -0.832 . . . . 0.0 109.744 -179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 32.2 t30 -80.84 -33.01 34.92 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.172 -0.955 . . . . 0.0 109.583 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.473 ' O ' ' HB ' ' B' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.489 ' O ' HG22 ' B' ' 2' ' ' ILE . 1.9 mp 62.44 91.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.344 -1.092 . . . . 0.0 109.743 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -159.14 24.45 0.32 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.1 OUTLIER -146.36 -41.37 0.2 Allowed 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.72 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 10.1 m-85 -67.85 -15.65 63.72 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.559 -0.713 . . . . 0.0 109.713 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.619 HD22 HD11 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -112.16 -11.74 13.74 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.439 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -129.02 -11.12 4.78 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.882 -1.136 . . . . 0.0 110.225 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.74 -31.09 2.72 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.856 -1.152 . . . . 0.0 109.913 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -77.16 -61.91 1.83 Allowed 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.111 -0.993 . . . . 0.0 108.969 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.444 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -40.58 -51.97 2.9 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.232 -179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttm -50.23 -64.74 0.71 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.935 -1.103 . . . . 0.0 109.397 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.494 ' O ' ' N ' ' B' ' 16' ' ' TRP . 4.9 m-30 -64.12 -34.05 77.16 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.206 -0.934 . . . . 0.0 109.155 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.622 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -42.32 -38.26 2.73 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 108.858 -1.697 . . . . 0.0 108.858 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.67 -17.67 24.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.476 -1.014 . . . . 0.0 110.36 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.7 -45.23 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.908 -1.12 . . . . 0.0 110.531 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.701 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -54.9 -43.76 73.54 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.127 -0.983 . . . . 0.0 109.578 -179.718 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.4 OUTLIER -59.73 -52.92 55.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.093 -1.004 . . . . 0.0 108.634 179.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.561 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.8 -18.21 8.01 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 108.921 -1.672 . . . . 0.0 108.921 179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.723 ' HB2' HD21 ' A' ' 6' ' ' LEU . 4.3 mm-40 -87.06 -65.64 0.99 Allowed 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.382 -1.069 . . . . 0.0 108.332 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 1.046 HG13 HD22 ' A' ' 6' ' ' LEU . 10.7 mt -73.04 -49.92 35.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 CA-C-O 121.775 0.798 . . . . 0.0 109.295 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.72 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -57.76 -23.96 54.72 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.812 -0.555 . . . . 0.0 109.864 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' B' ' 18' ' ' GLY . 13.5 t30 -101.93 -34.5 9.34 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.171 -0.956 . . . . 0.0 109.558 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 6.0 t . . . . . 0 N--CA 1.489 1.513 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.481 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.9 mt -136.14 140.52 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.309 -1.113 . . . . 0.0 109.312 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.557 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . 118.42 31.69 1.48 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.87 -41.34 0.06 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.897 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -82.31 -10.9 58.92 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 179.393 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.874 ' N ' HD22 ' A' ' 6' ' ' LEU . 1.6 mm? -114.06 10.06 17.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.277 -0.89 . . . . 0.0 109.663 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.557 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 19.1 m-70 -131.14 -31.64 1.66 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.112 -0.992 . . . . 0.0 110.076 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 11' ' ' LYS . 0.6 OUTLIER -127.6 -29.96 2.6 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.031 -1.043 . . . . 0.0 109.853 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.897 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -51.19 -75.72 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.077 -1.015 . . . . 0.0 108.841 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' C ' ' O ' ' A' ' 9' ' ' ALA . 18.7 tttp -29.16 -42.66 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.637 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 8' ' ' SER . 13.6 mttm -55.66 -64.08 0.97 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.958 -1.089 . . . . 0.0 108.335 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' O ' ' CD1' ' A' ' 16' ' ' TRP . 1.4 m-85 -71.61 -27.13 62.9 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -51.06 -44.67 51.16 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.308 -1.517 . . . . 0.0 109.308 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HE3' ' HB3' ' A' ' 14' ' ' LYS . 15.0 mmmt -85.75 -13.31 48.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.335 -1.097 . . . . 0.0 110.081 -179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -100.21 -49.41 4.28 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.909 -1.119 . . . . 0.0 110.265 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.67 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.8 p-90 -60.42 -41.68 94.44 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 110.36 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.595 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -58.24 -53.11 50.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 120.979 -1.076 . . . . 0.0 108.846 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -54.27 -17.25 7.66 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.585 ' OE1' HG21 ' B' ' 2' ' ' ILE . 8.6 mm-40 -88.95 -65.42 1.02 Allowed 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.374 -1.074 . . . . 0.0 108.438 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.59 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 15.7 mt -71.7 -49.64 44.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-O 121.548 0.69 . . . . 0.0 109.677 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.56 ' HG3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -56.58 -20.32 20.28 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.458 -0.776 . . . . 0.0 109.812 -179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 8.0 t30 -102.25 -36.86 8.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.628 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.496 179.924 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.585 HG21 ' OE1' ' A' ' 19' ' ' GLU . 5.6 pt -111.56 92.86 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.296 -1.12 . . . . 0.0 109.5 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.575 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . -126.43 25.07 5.47 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -148.61 -46.03 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.414 -1.051 . . . . 0.0 108.278 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.67 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 4.5 m-85 -70.02 -15.31 62.99 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.522 -0.736 . . . . 0.0 109.066 178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.556 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.5 OUTLIER -113.71 6.56 16.88 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.516 -0.873 . . . . 0.0 110.11 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.575 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 11.9 m-70 -141.29 12.91 2.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.998 -1.064 . . . . 0.0 109.908 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.439 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.0 OUTLIER -164.89 -35.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.0 109.875 179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.633 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -62.11 -63.52 1.22 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.075 -1.015 . . . . 0.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.505 ' C ' ' O ' ' B' ' 9' ' ' ALA . 6.2 ttpt -33.24 -44.72 0.13 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-O 121.237 0.541 . . . . 0.0 110.048 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 9.1 mtpp -52.1 -66.45 0.38 Allowed 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.556 ' O ' ' CD1' ' B' ' 16' ' ' TRP . 1.4 m-85 -69.33 -17.93 63.76 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.585 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -57.06 -39.8 90.31 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 108.885 -1.686 . . . . 0.0 108.885 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -88.21 -37.85 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.407 -1.054 . . . . 0.0 109.968 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.92 -47.21 21.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.0 109.55 -179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.692 ' CB ' ' HB1' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -62.8 -50.57 70.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.234 -0.916 . . . . 0.0 109.188 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.865 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -68.57 -43.76 83.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 120.744 -1.222 . . . . 0.0 108.049 -179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' B' ' 22' ' ' ASN . . . -58.8 -13.47 18.59 Favored Glycine 0 N--CA 1.486 1.998 0 N-CA-C 107.922 -2.071 . . . . 0.0 107.922 177.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.537 ' CA ' ' OE1' ' B' ' 19' ' ' GLU . 1.1 tp10 -91.89 -68.82 0.77 Allowed 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.783 HD11 HD12 ' A' ' 6' ' ' LEU . 60.0 mt -73.15 -47.2 48.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.261 -0.976 . . . . 0.0 109.888 -179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.865 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.9 tmm? -53.97 -24.67 17.41 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 1.0 OUTLIER -72.22 -60.34 2.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.1 -1.0 . . . . 0.0 109.452 179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.57 -179.834 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -135.71 83.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.328 -1.101 . . . . 0.0 109.54 179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.492 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -137.18 55.8 0.69 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.728 -1.749 . . . . 0.0 108.728 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 3' ' ' GLY . 6.6 tttt 175.84 -48.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.689 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 4.5 m-85 -69.92 -14.29 62.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.569 HD22 ' O ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -114.31 -1.48 13.55 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.377 -0.827 . . . . 0.0 110.034 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.492 ' CD2' ' HA2' ' A' ' 3' ' ' GLY . 7.1 m-70 -134.84 10.37 3.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.975 -1.078 . . . . 0.0 109.879 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.534 ' O ' ' CE2' ' A' ' 12' ' ' PHE . 3.9 t -157.98 -37.66 0.07 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 0.0 109.621 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.06 -64.19 0.98 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.046 -1.034 . . . . 0.0 108.942 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.518 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -30.24 -51.97 0.15 Allowed 'General case' 0 N--CA 1.5 2.067 0 CA-C-O 121.105 0.479 . . . . 0.0 110.284 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.4 mttt -47.14 -67.06 0.31 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.108 -0.995 . . . . 0.0 108.536 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.534 ' CE2' ' O ' ' A' ' 8' ' ' SER . 3.2 m-85 -66.16 -39.16 89.56 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.431 -0.951 . . . . 0.0 108.431 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.81 -32.76 2.29 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -96.67 -15.54 21.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.324 -1.104 . . . . 0.0 109.943 -179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -103.38 -48.09 4.1 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.108 -0.995 . . . . 0.0 109.906 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.738 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.3 p-90 -58.72 -43.04 90.01 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.111 -0.993 . . . . 0.0 109.869 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.633 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.5 OUTLIER -57.18 -52.0 61.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.042 -1.036 . . . . 0.0 109.1 -179.645 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.58 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.14 -15.51 10.83 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 179.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.535 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 2.9 mm-40 -91.32 -64.11 1.17 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.378 -1.072 . . . . 0.0 108.71 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 6.1 mt -71.48 -50.57 39.22 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.509 0.671 . . . . 0.0 110.132 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.63 ' HB3' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -63.27 -19.67 64.78 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.4 -0.812 . . . . 0.0 109.742 -178.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 35.6 t30 -109.19 9.23 26.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.229 -0.92 . . . . 0.0 109.5 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 19' ' ' GLU . 26.8 t . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.586 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.618 HG21 ' HG ' ' B' ' 6' ' ' LEU . 2.5 mp -95.45 85.78 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.268 -1.137 . . . . 0.0 109.627 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.567 ' HA2' ' CD2' ' B' ' 7' ' ' HIS . . . -142.14 59.5 0.55 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.136 -1.585 . . . . 0.0 109.136 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.469 ' HB2' ' O ' ' B' ' 3' ' ' GLY . 25.1 tttt 175.31 -46.22 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.738 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 1.9 m-85 -76.01 -17.09 59.83 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.618 ' HG ' HG21 ' B' ' 2' ' ' ILE . 0.7 OUTLIER -112.69 14.34 20.0 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.434 -0.791 . . . . 0.0 109.779 179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.567 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 18.2 m-70 -142.36 -32.97 0.49 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.208 -0.932 . . . . 0.0 110.284 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 2.5 m -119.25 -32.38 4.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.757 -1.214 . . . . 0.0 109.9 -179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.612 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.1 -67.18 0.43 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.048 -1.033 . . . . 0.0 109.35 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 8.6 ptmm? -30.85 -39.2 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 122.075 -0.391 . . . . 0.0 110.877 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.522 ' N ' ' HG3' ' B' ' 10' ' ' LYS . 0.4 OUTLIER -62.01 -62.95 1.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.987 -1.071 . . . . 0.0 108.788 179.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.425 ' CD1' ' N ' ' B' ' 12' ' ' PHE . 1.1 m-85 -71.16 -31.85 68.2 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.631 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -46.94 -38.01 9.99 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 10.1 mttp -91.52 -20.35 21.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -1.128 . . . . 0.0 110.339 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.541 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -92.17 -56.8 2.92 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.091 -1.006 . . . . 0.0 109.492 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.689 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -49.83 -46.02 50.78 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.774 -0.579 . . . . 0.0 109.657 -179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.616 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -56.93 -53.39 43.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 C-N-CA 119.074 -1.05 . . . . 0.0 108.244 179.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.549 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -54.13 -17.72 8.14 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.541 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 9.3 mm-40 -88.33 -66.42 0.92 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.145 -1.209 . . . . 0.0 108.301 179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.6 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 29.8 mt -71.22 -49.21 49.89 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-O 121.617 0.723 . . . . 0.0 109.555 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.601 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.5 OUTLIER -55.13 -19.23 7.04 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.6 -0.688 . . . . 0.0 109.747 -179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 26.8 t30 -102.84 -21.89 13.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.079 -1.013 . . . . 0.0 109.214 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.489 1.483 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.354 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.706 HD11 ' HG ' ' A' ' 6' ' ' LEU . 3.9 tt -84.53 106.27 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.281 -1.129 . . . . 0.0 109.477 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.518 ' HA2' ' NE2' ' A' ' 7' ' ' HIS . . . -150.61 17.76 0.99 Allowed Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -136.22 -41.56 0.65 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.532 -0.981 . . . . 0.0 108.472 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.814 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 14.4 m-85 -69.9 -24.84 63.46 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 121.389 0.614 . . . . 0.0 109.82 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.706 ' HG ' HD11 ' A' ' 2' ' ' ILE . 0.8 OUTLIER -111.73 20.55 16.96 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.335 -0.853 . . . . 0.0 109.346 -179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.541 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 1.5 m-70 -151.61 -28.42 0.18 Allowed 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.335 -0.946 . . . . 0.0 110.341 -178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -130.6 -2.59 4.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 120.698 -1.251 . . . . 0.0 110.266 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -92.24 -63.8 1.19 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.005 -1.059 . . . . 0.0 109.066 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.526 ' HG3' ' CD1' ' B' ' 20' ' ' ILE . 1.4 ttmt -36.46 -46.15 0.54 Allowed 'General case' 0 N--CA 1.496 1.857 0 C-N-CA 120.323 -0.551 . . . . 0.0 110.487 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.3 mtpt -51.03 -65.46 0.55 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.011 -1.055 . . . . 0.0 109.177 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.505 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.5 m-85 -70.96 -22.8 62.16 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.601 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -53.48 -35.21 50.68 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -91.31 -27.47 18.38 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.47 -1.018 . . . . 0.0 110.274 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.89 -47.73 7.15 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.954 -179.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.675 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.2 OUTLIER -59.76 -43.44 94.32 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.253 -0.905 . . . . 0.0 109.451 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.758 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -68.36 -52.28 38.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 O-C-N 120.714 -1.241 . . . . 0.0 108.388 -179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -53.31 -16.74 5.07 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 108.198 -1.961 . . . . 0.0 108.198 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 4.5 tp10 -86.65 -72.44 0.5 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.023 HD11 HD13 ' B' ' 6' ' ' LEU . 79.5 mt -70.47 -47.45 65.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 C-N-CA 119.272 -0.971 . . . . 0.0 109.685 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.758 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -51.93 -22.43 3.86 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.401 -0.812 . . . . 0.0 109.683 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 2.6 m-80 -100.49 -23.8 14.63 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.09 -1.007 . . . . 0.0 109.489 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.6 t . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.519 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.7 ' N ' HD12 ' B' ' 2' ' ' ILE . 2.0 mp -113.51 174.66 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.255 -1.144 . . . . 0.0 109.386 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . 0.615 ' H ' HG22 ' B' ' 2' ' ' ILE . . . 111.98 11.08 17.09 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.528 ' HG3' ' CD2' ' B' ' 5' ' ' TYR . 0.3 OUTLIER -137.1 -45.94 0.57 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.361 -1.082 . . . . 0.0 108.445 179.394 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.675 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 8.2 m-85 -72.15 -14.58 61.86 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.523 -0.736 . . . . 0.0 109.491 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 1.023 HD13 HD11 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -111.58 5.43 19.39 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.159 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.587 ' CD2' ' HA2' ' B' ' 3' ' ' GLY . 16.8 m-70 -138.29 15.31 2.79 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.088 -1.008 . . . . 0.0 110.025 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -168.94 -35.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.018 -1.051 . . . . 0.0 109.829 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.635 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.46 -64.06 0.97 Allowed 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.082 -1.012 . . . . 0.0 109.239 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.527 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.5 OUTLIER -33.57 -48.47 0.26 Allowed 'General case' 0 N--CA 1.498 1.933 0 CA-C-O 121.172 0.51 . . . . 0.0 110.035 -179.952 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -53.48 -64.33 0.86 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.182 -0.949 . . . . 0.0 108.723 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.603 ' HA ' ' HB3' ' B' ' 15' ' ' ALA . 3.6 m-85 -63.95 -30.11 71.22 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.304 -0.872 . . . . 0.0 108.735 179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.598 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.04 -40.61 28.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -97.36 -11.75 23.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.482 -1.01 . . . . 0.0 109.454 179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' B' ' 12' ' ' PHE . . . -102.88 -5.48 23.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.181 -0.949 . . . . 0.0 109.928 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.814 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -109.9 -44.27 3.84 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.232 -0.917 . . . . 0.0 109.285 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.766 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.5 OUTLIER -59.02 -52.24 63.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.215 -0.994 . . . . 0.0 108.428 -179.911 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.571 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -53.72 -18.39 8.05 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.519 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 30.8 mm-40 -88.72 -65.28 1.03 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.382 -1.069 . . . . 0.0 108.647 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.586 HD11 HD13 ' A' ' 6' ' ' LEU . 7.0 mt -70.56 -50.91 41.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 121.436 0.636 . . . . 0.0 110.191 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.766 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -59.69 -25.69 64.97 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.443 -0.786 . . . . 0.0 109.898 -178.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.477 ' N ' ' HG3' ' B' ' 21' ' ' MET . 35.1 t30 -96.74 -46.36 6.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.411 ' OXT' ' O ' ' B' ' 22' ' ' ASN . 9.2 t . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.566 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.0 mt -85.29 86.88 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.198 -1.177 . . . . 0.0 109.442 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.465 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -154.83 27.87 0.65 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 3' ' ' GLY . 0.0 OUTLIER -147.26 -41.78 0.18 Allowed 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.717 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 18.7 m-85 -68.51 -22.69 64.51 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.487 -0.758 . . . . 0.0 109.081 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.852 HD13 HD11 ' B' ' 20' ' ' ILE . 2.0 mm? -108.43 7.06 26.8 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.375 -0.828 . . . . 0.0 109.911 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.487 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 14.4 m-70 -140.31 12.51 2.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.031 -1.043 . . . . 0.0 109.75 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -165.85 -36.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.086 -1.009 . . . . 0.0 109.798 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.717 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -60.4 -70.89 0.15 Allowed 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.151 -1.019 . . . . 0.0 108.71 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.577 ' HD3' ' CD1' ' B' ' 20' ' ' ILE . 5.3 mtpt -30.78 -53.88 0.19 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 121.078 0.466 . . . . 0.0 110.401 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' C ' ' O ' ' A' ' 10' ' ' LYS . 8.5 mttt -45.69 -65.83 0.49 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.535 ' O ' ' N ' ' A' ' 16' ' ' TRP . 10.4 m-85 -66.23 -30.22 70.62 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.594 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -44.65 -38.4 5.5 Favored Glycine 0 N--CA 1.487 2.071 0 N-CA-C 108.861 -1.696 . . . . 0.0 108.861 179.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.3 mttt -94.46 -18.49 21.45 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.426 -1.043 . . . . 0.0 109.891 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' O ' ' CG ' ' A' ' 19' ' ' GLU . . . -102.43 2.64 36.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.061 -1.024 . . . . 0.0 110.086 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.748 ' CZ2' HG23 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -121.23 -47.03 2.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.216 -0.927 . . . . 0.0 109.199 179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG23 ' CZ2' ' A' ' 16' ' ' TRP . 0.4 OUTLIER -60.84 -50.79 79.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.424 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.78 -15.8 14.33 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 178.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' A' ' 15' ' ' ALA . 1.0 OUTLIER -91.32 -65.75 0.99 Allowed 'General case' 0 C--N 1.307 -1.245 0 O-C-N 121.434 -1.039 . . . . 0.0 108.529 179.415 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.596 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 39.0 mt -73.1 -47.82 46.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 121.499 0.666 . . . . 0.0 109.653 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.536 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -59.06 -18.47 35.28 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.372 -0.83 . . . . 0.0 109.73 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 27.4 m-20 -103.55 -34.47 8.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.937 . . . . 0.0 109.22 179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.7 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.962 -1.018 . . . . 0.0 109.455 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 2.9 pt -149.11 73.15 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.178 -1.189 . . . . 0.0 109.662 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -124.14 -17.92 2.93 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.97 -10.88 9.77 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.08 -1.247 . . . . 0.0 108.995 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.663 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 2.0 m-85 -94.58 -17.74 22.05 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.374 -0.829 . . . . 0.0 109.256 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.58 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.6 OUTLIER -114.9 16.68 17.21 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.094 -1.004 . . . . 0.0 109.529 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.538 ' CD2' ' N ' ' B' ' 7' ' ' HIS . 0.6 OUTLIER -152.81 -30.41 0.14 Allowed 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.356 -179.231 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.483 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 1.6 m -120.28 -5.18 9.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.805 -1.184 . . . . 0.0 109.798 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.623 ' CB ' ' HA ' ' B' ' 5' ' ' TYR . . . -96.41 -58.75 1.98 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.214 -0.929 . . . . 0.0 109.15 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.5 ' HD2' ' HG2' ' B' ' 11' ' ' LYS . 0.0 OUTLIER -39.64 -34.78 0.26 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.692 -0.63 . . . . 0.0 109.815 -179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.5 ' HG2' ' HD2' ' B' ' 10' ' ' LYS . 0.1 OUTLIER -59.04 -66.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.253 179.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.541 ' O ' ' N ' ' B' ' 16' ' ' TRP . 11.6 m-85 -67.3 -20.85 65.68 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.581 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -51.45 -37.15 39.72 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 108.814 -1.714 . . . . 0.0 108.814 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.3 mmpt? -91.04 -41.26 11.18 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.605 -0.938 . . . . 0.0 109.988 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.76 -45.32 29.55 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.037 -1.04 . . . . 0.0 110.02 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.695 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.0 OUTLIER -62.73 -49.98 72.88 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.217 -0.927 . . . . 0.0 109.757 -179.603 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.724 HG22 ' HB3' ' B' ' 21' ' ' MET . 0.3 OUTLIER -64.79 -52.77 50.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.679 -1.263 . . . . 0.0 109.399 -178.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.574 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -52.26 -18.11 4.6 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 108.441 -1.864 . . . . 0.0 108.441 178.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.527 ' HG3' ' N ' ' B' ' 20' ' ' ILE . 5.5 tp10 -87.21 -69.29 0.69 Allowed 'General case' 0 C--N 1.307 -1.269 0 O-C-N 121.637 -0.919 . . . . 0.0 108.545 179.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.852 HD11 HD13 ' A' ' 6' ' ' LEU . 6.0 mt -68.5 -49.47 65.27 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 C-N-CA 120.077 -0.649 . . . . 0.0 110.584 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.724 ' HB3' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER -61.43 -19.03 61.51 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.311 -0.868 . . . . 0.0 110.034 -178.505 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 1.8 m-20 -66.41 -58.32 5.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.139 -0.976 . . . . 0.0 109.606 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 117.938 -1.029 . . . . 0.0 109.535 -179.968 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.289 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.776 ' O ' HG22 ' A' ' 2' ' ' ILE . 54.7 mt 56.83 41.54 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -1.141 . . . . 0.0 109.562 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -149.67 20.45 1.15 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.05 -41.89 0.27 Allowed 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.748 ' C ' HD22 ' A' ' 6' ' ' LEU . 10.7 m-85 -65.34 -20.82 66.56 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.53 -0.732 . . . . 0.0 109.035 178.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.914 HD13 HD11 ' B' ' 20' ' ' ILE . 3.5 mm? -107.66 5.25 26.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.482 -0.887 . . . . 0.0 109.888 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.478 ' ND1' ' O ' ' A' ' 6' ' ' LEU . 9.1 m-70 -136.92 9.88 3.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.128 -0.982 . . . . 0.0 110.166 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -163.23 -36.32 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.062 -1.024 . . . . 0.0 109.823 179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.638 ' HB1' ' CG ' ' B' ' 16' ' ' TRP . . . -63.16 -67.55 0.42 Allowed 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 119.216 -0.994 . . . . 0.0 108.537 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.603 ' HD2' HD11 ' B' ' 20' ' ' ILE . 14.0 mtpt -30.03 -56.74 0.18 Allowed 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.694 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 10' ' ' LYS . 1.0 OUTLIER -44.29 -66.27 0.41 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.193 -0.942 . . . . 0.0 109.074 -179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.543 ' O ' ' N ' ' A' ' 16' ' ' TRP . 2.1 m-85 -66.21 -33.06 74.9 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.28 -1.008 . . . . 0.0 108.28 179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.563 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.6 -32.36 1.98 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.73 -26.88 13.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -1.143 . . . . 0.0 109.672 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.74 -46.11 8.44 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.263 -0.898 . . . . 0.0 109.873 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.69 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -60.12 -44.63 94.73 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.285 -0.885 . . . . 0.0 109.589 -179.713 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.783 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.6 OUTLIER -63.17 -50.28 79.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.501 -1.374 . . . . 0.0 109.014 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.51 -15.18 10.88 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 108.371 -1.892 . . . . 0.0 108.371 178.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.577 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -88.39 -69.08 0.72 Allowed 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.655 HD11 HD13 ' B' ' 6' ' ' LEU . 68.2 mt -71.92 -48.11 52.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.565 -179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.783 ' HB2' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -54.94 -19.06 5.85 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.392 -0.817 . . . . 0.0 109.417 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 20.1 t-20 -80.82 -35.85 32.4 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 0.0 109.117 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.331 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.422 ' C ' HD12 ' B' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.545 ' N ' HD12 ' B' ' 2' ' ' ILE . 5.3 mp 51.66 78.65 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.187 -1.184 . . . . 0.0 109.53 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -150.57 18.26 1.0 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.67 -44.68 0.67 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.421 -1.046 . . . . 0.0 108.605 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.69 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 36.8 m-85 -64.16 -17.79 63.85 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.379 -0.826 . . . . 0.0 109.448 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.655 HD13 HD11 ' A' ' 20' ' ' ILE . 1.3 mm? -110.37 -9.81 14.61 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.249 -0.907 . . . . 0.0 110.48 -179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.0 m-70 -128.03 12.19 6.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.964 -1.085 . . . . 0.0 110.158 -179.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 32.7 t -158.24 -37.38 0.07 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.028 -1.045 . . . . 0.0 110.108 179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.61 ' HB1' ' CB ' ' A' ' 16' ' ' TRP . . . -66.18 -65.02 0.73 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.103 -0.998 . . . . 0.0 109.174 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.477 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -38.57 -47.88 1.36 Allowed 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.246 -0.582 . . . . 0.0 109.633 -179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 11' ' ' LYS . 1.3 mptm? -45.89 -68.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.527 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.8 m-85 -64.07 -29.82 70.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.565 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.89 -36.71 3.82 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -90.74 -29.96 17.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.38 -1.071 . . . . 0.0 110.107 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.94 -48.09 7.44 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.058 -1.026 . . . . 0.0 110.007 -179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -61.92 -44.71 96.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.246 -0.909 . . . . 0.0 109.316 -179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.706 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -66.75 -49.13 77.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.586 -1.321 . . . . 0.0 108.627 -179.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.504 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -57.17 -15.43 14.76 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 108.039 -2.024 . . . . 0.0 108.039 178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.672 ' HG2' HD21 ' A' ' 6' ' ' LEU . 3.5 tp10 -86.82 -72.5 0.5 Allowed 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.914 HD11 HD13 ' A' ' 6' ' ' LEU . 85.3 mt -70.11 -48.19 63.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 119.244 -0.982 . . . . 0.0 109.924 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.706 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -55.26 -24.49 28.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.393 -0.817 . . . . 0.0 109.615 -179.329 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.489 ' HB2' ' O ' ' B' ' 18' ' ' GLY . 44.5 t30 -83.54 -30.91 26.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.164 -0.96 . . . . 0.0 109.543 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.375 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.332 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.501 ' CG1' ' O ' ' A' ' 2' ' ' ILE . 4.9 pt -79.85 115.44 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.244 -1.151 . . . . 0.0 109.318 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -138.3 11.88 3.54 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.77 -39.69 0.63 Allowed 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.694 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 23.6 m-85 -66.8 -21.89 66.03 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.523 -0.736 . . . . 0.0 109.344 179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.012 HD13 HD11 ' B' ' 20' ' ' ILE . 2.1 mm? -107.43 2.41 24.27 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.245 -0.909 . . . . 0.0 109.912 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -137.18 18.02 2.98 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.126 -0.984 . . . . 0.0 109.685 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.1 t -169.49 -37.93 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.189 -0.944 . . . . 0.0 109.953 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.675 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.81 -66.75 0.49 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.064 -1.022 . . . . 0.0 108.88 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.513 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.8 OUTLIER -30.31 -52.12 0.15 Allowed 'General case' 0 N--CA 1.499 2.006 0 CA-C-O 121.058 0.456 . . . . 0.0 110.343 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 10' ' ' LYS . 4.0 mmtp -44.76 -67.35 0.29 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.24 -0.913 . . . . 0.0 108.568 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.514 ' O ' ' N ' ' A' ' 16' ' ' TRP . 3.3 m-85 -67.29 -33.54 75.52 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.57 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.63 -30.58 1.51 Allowed Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -97.73 -34.29 10.96 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.324 -1.103 . . . . 0.0 110.087 -179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HB3' ' CE1' ' B' ' 5' ' ' TYR . . . -86.5 -38.18 17.51 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.092 -1.005 . . . . 0.0 109.895 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.645 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.1 OUTLIER -71.02 -45.81 63.26 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.136 -0.977 . . . . 0.0 109.797 -179.634 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.71 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -65.73 -51.06 66.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.45 -1.406 . . . . 0.0 108.803 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -55.92 -15.45 9.89 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 108.184 -1.966 . . . . 0.0 108.184 178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.534 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.0 tp10 -87.22 -71.32 0.57 Allowed 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 1.025 HD11 HD13 ' B' ' 6' ' ' LEU . 79.0 mt -71.42 -47.67 57.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.407 -0.917 . . . . 0.0 109.692 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.71 ' HB2' HG22 ' A' ' 17' ' ' VAL . 1.6 tmm? -55.26 -19.51 8.54 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.38 -0.825 . . . . 0.0 109.595 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.6 OUTLIER -78.68 -46.25 19.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.151 -0.968 . . . . 0.0 109.468 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.033 -0.984 . . . . 0.0 109.518 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 1.8 pt -143.97 64.39 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.185 -1.186 . . . . 0.0 109.757 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -128.69 9.66 6.43 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.91 -39.35 0.62 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.342 -1.093 . . . . 0.0 108.125 179.206 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.645 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 30.1 m-85 -68.93 -25.79 64.75 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.44 -0.787 . . . . 0.0 109.494 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 1.025 HD13 HD11 ' A' ' 20' ' ' ILE . 3.2 mm? -103.95 9.64 36.58 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.242 -0.983 . . . . 0.0 110.013 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.494 ' ND1' ' O ' ' B' ' 6' ' ' LEU . 20.4 m-70 -138.47 13.34 2.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 120.955 -1.091 . . . . 0.0 110.156 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.469 ' HG ' ' HE2' ' B' ' 12' ' ' PHE . 0.3 OUTLIER -171.16 -34.22 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.895 -1.128 . . . . 0.0 110.186 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.637 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -64.31 -66.11 0.59 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.107 -0.996 . . . . 0.0 109.173 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.594 ' HD2' HD13 ' A' ' 20' ' ' ILE . 8.3 mtpt -31.3 -50.74 0.17 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.142 0.496 . . . . 0.0 110.292 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -49.18 -64.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 0.0 108.833 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.512 ' O ' ' N ' ' B' ' 16' ' ' TRP . 3.1 m-85 -68.42 -22.23 64.62 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.733 -0.839 . . . . 0.0 108.733 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.568 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -56.25 -35.22 64.46 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -90.96 -29.03 17.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.263 -1.14 . . . . 0.0 110.091 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.24 -46.08 8.66 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.037 -1.039 . . . . 0.0 109.856 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.847 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.0 OUTLIER -62.98 -47.69 82.06 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.347 -0.846 . . . . 0.0 109.407 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.847 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -68.94 -48.17 71.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 120.769 -1.207 . . . . 0.0 108.026 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.437 ' N ' HG12 ' B' ' 17' ' ' VAL . . . -55.83 -16.85 13.38 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 107.831 -2.107 . . . . 0.0 107.831 177.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -87.69 -71.9 0.55 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 1.012 HD11 HD13 ' A' ' 6' ' ' LEU . 49.9 mt -70.73 -48.13 59.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.708 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.669 ' HB2' HG22 ' B' ' 17' ' ' VAL . 1.5 tmm? -56.95 -19.25 16.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.404 -0.81 . . . . 0.0 109.558 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.28 -60.25 2.47 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.108 -0.995 . . . . 0.0 109.287 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.501 179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 28.3 mm 59.4 75.38 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.281 -1.129 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -144.52 13.71 2.02 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.7 -40.64 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.688 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 35.1 m-85 -63.98 -20.68 66.07 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.568 -0.708 . . . . 0.0 109.407 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.895 HD13 HD11 ' B' ' 20' ' ' ILE . 1.4 mm? -109.65 2.38 20.18 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.161 -179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -137.21 13.64 3.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.102 -0.999 . . . . 0.0 109.957 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 73.0 m -165.26 -36.26 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.091 -1.005 . . . . 0.0 110.142 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.624 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -63.54 -68.22 0.36 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.043 -1.035 . . . . 0.0 108.719 179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -28.67 -48.05 0.06 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.144 0.497 . . . . 0.0 110.542 179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -54.12 -63.2 1.23 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.117 -0.99 . . . . 0.0 108.701 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 16' ' ' TRP . 6.0 m-30 -69.82 -34.08 73.18 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.603 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -45.97 -38.51 8.22 Favored Glycine 0 N--CA 1.487 2.064 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 25.1 mtpt -95.07 -11.41 28.37 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.233 -1.157 . . . . 0.0 109.882 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -104.6 -52.14 2.94 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.236 -0.915 . . . . 0.0 109.841 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.677 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.2 p-90 -50.18 -42.77 51.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.495 -0.753 . . . . 0.0 109.435 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.627 ' N ' ' CD2' ' A' ' 16' ' ' TRP . 0.6 OUTLIER -54.3 -51.22 50.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.204 -0.935 . . . . 0.0 109.085 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -57.87 -14.03 15.22 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 178.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.549 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 23.7 mm-40 -92.92 -61.57 1.56 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.299 -1.118 . . . . 0.0 109.153 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.602 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 4.3 mt -74.51 -49.92 28.94 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-O 121.44 0.638 . . . . 0.0 110.071 -179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.555 ' CG ' ' O ' ' A' ' 17' ' ' VAL . 1.5 ppp? -64.14 -15.74 60.4 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.449 -0.782 . . . . 0.0 109.615 -178.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 18' ' ' GLY . 61.7 t30 -106.78 -30.14 9.11 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.238 -0.914 . . . . 0.0 109.361 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.405 ' CB ' ' O ' ' A' ' 19' ' ' GLU . 67.6 m . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.043 -0.979 . . . . 0.0 109.542 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 1.6 tt -174.95 162.01 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -1.164 . . . . 0.0 109.739 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.6 -8.91 3.42 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.586 -1.405 . . . . 0.0 109.586 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' B' ' 8' ' ' SER . 0.2 OUTLIER -129.18 -39.36 1.54 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.677 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 19.2 m-85 -59.44 -23.12 62.41 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.654 -0.654 . . . . 0.0 109.244 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.604 HD22 ' O ' ' B' ' 5' ' ' TYR . 0.8 OUTLIER -113.34 -4.89 13.6 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.569 -179.311 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -134.92 1.19 2.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.939 -1.1 . . . . 0.0 110.118 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.475 ' N ' ' O ' ' B' ' 4' ' ' LYS . 14.5 m -141.9 -38.19 0.39 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.04 -1.037 . . . . 0.0 109.459 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.614 ' CB ' ' CB ' ' A' ' 16' ' ' TRP . . . -67.2 -63.31 1.09 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.235 -0.915 . . . . 0.0 108.952 179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.497 ' HD3' ' O ' ' B' ' 6' ' ' LEU . 6.9 ptmt -33.31 -48.72 0.25 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-O 121.116 0.484 . . . . 0.0 110.459 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' B' ' 11' ' ' LYS . 23.6 mmtt -56.0 -61.15 2.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.934 -1.103 . . . . 0.0 108.837 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' B' ' 16' ' ' TRP . 1.7 m-85 -67.27 -27.03 66.85 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 108.804 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.54 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -49.29 -43.47 34.13 Favored Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.787 -1.725 . . . . 0.0 108.787 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.39 -22.34 25.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -1.036 . . . . 0.0 110.24 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.67 -49.54 5.82 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.992 -1.068 . . . . 0.0 109.971 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.688 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 0.3 OUTLIER -61.09 -45.95 92.63 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.376 -0.828 . . . . 0.0 109.364 -179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' B' ' 21' ' ' MET . 0.3 OUTLIER -63.57 -48.75 85.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.595 -1.316 . . . . 0.0 108.62 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.529 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.1 -13.38 14.46 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.364 -1.894 . . . . 0.0 108.364 178.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.547 ' HB3' ' O ' ' B' ' 16' ' ' TRP . 4.7 tp10 -90.63 -67.85 0.82 Allowed 'General case' 0 C--N 1.309 -1.19 0 O-C-N 121.568 -0.96 . . . . 0.0 108.642 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.895 HD11 HD13 ' A' ' 6' ' ' LEU . 60.8 mt -75.88 -40.06 38.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.984 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.744 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.6 OUTLIER -63.06 -19.85 64.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.328 -0.857 . . . . 0.0 109.93 -179.377 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.478 ' OD1' ' O ' ' B' ' 19' ' ' GLU . 3.4 p-10 -106.88 -19.05 13.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.947 -1.096 . . . . 0.0 109.588 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.441 ' N ' ' OD1' ' B' ' 22' ' ' ASN . 46.4 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -153.66 70.51 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.176 -1.191 . . . . 0.0 109.74 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 7' ' ' HIS . . . -120.93 3.02 11.75 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -133.39 -35.01 1.03 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -1.052 . . . . 0.0 108.538 179.225 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 9' ' ' ALA . 1.9 m-85 -75.04 -20.5 59.54 Favored 'General case' 0 C--N 1.306 -1.287 0 O-C-N 121.47 -0.769 . . . . 0.0 109.367 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.62 HD22 ' O ' ' A' ' 5' ' ' TYR . 1.1 mm? -114.65 6.91 15.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.162 -0.962 . . . . 0.0 109.908 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.44 ' CG ' ' C ' ' A' ' 6' ' ' LEU . 3.4 m-70 -147.84 14.78 1.06 Allowed 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.171 -0.956 . . . . 0.0 109.334 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.7 t -159.95 -39.42 0.05 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.418 -0.801 . . . . 0.0 109.125 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.669 ' HB2' ' HA ' ' A' ' 5' ' ' TYR . . . -61.75 -65.77 0.64 Allowed 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.349 -0.844 . . . . 0.0 108.951 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -25.0 -54.15 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.18 0 CA-C-O 121.19 0.519 . . . . 0.0 110.763 -179.852 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -49.03 -64.26 0.86 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.11 -0.994 . . . . 0.0 108.816 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.595 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -71.44 -36.99 71.44 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.586 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -43.86 -33.4 2.55 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.994 -1.643 . . . . 0.0 108.994 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.549 ' HE2' ' CH2' ' B' ' 16' ' ' TRP . 2.2 mptp? -95.11 -22.92 17.56 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -1.098 . . . . 0.0 109.841 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -96.76 -47.95 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 0.0 109.758 -179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.71 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 0.4 OUTLIER -61.73 -43.13 99.45 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.27 -0.894 . . . . 0.0 108.968 179.821 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.686 HG22 ' HB2' ' A' ' 21' ' ' MET . 0.3 OUTLIER -67.61 -49.86 66.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 120.732 -1.23 . . . . 0.0 108.29 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -56.75 -14.79 10.44 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 177.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.551 ' HB3' ' O ' ' A' ' 16' ' ' TRP . 3.4 tp10 -88.58 -71.61 0.58 Allowed 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.659 HG12 HD11 ' B' ' 6' ' ' LEU . 67.4 mt -70.4 -48.18 61.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 119.47 -0.892 . . . . 0.0 109.551 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.686 ' HB2' HG22 ' A' ' 17' ' ' VAL . 2.8 tmm? -52.41 -20.5 2.87 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.381 -0.824 . . . . 0.0 109.349 -179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 18' ' ' GLY . 0.7 OUTLIER -86.31 -34.89 20.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.532 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 50.2 m . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.669 -179.826 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . . . . . . . . . 4.4 mt 62.67 63.39 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.237 -1.155 . . . . 0.0 109.514 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -141.54 22.09 2.54 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.932 -1.667 . . . . 0.0 108.932 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.97 -47.54 0.32 Allowed 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.71 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 20.6 m-85 -62.07 -17.78 58.59 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.596 -0.69 . . . . 0.0 109.583 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.659 HD11 HG12 ' A' ' 20' ' ' ILE . 1.0 OUTLIER -109.45 -2.27 17.81 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.055 -179.366 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -135.36 19.11 3.37 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.095 -1.003 . . . . 0.0 109.688 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . 0.517 ' O ' ' CE2' ' B' ' 12' ' ' PHE . 0.5 OUTLIER -167.27 -37.67 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.08 -1.013 . . . . 0.0 110.063 179.865 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.605 ' HB1' ' CG ' ' A' ' 16' ' ' TRP . . . -66.82 -62.53 1.39 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 120.991 -1.068 . . . . 0.0 109.554 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.502 ' C ' ' O ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -35.05 -47.19 0.36 Allowed 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 121.134 0.492 . . . . 0.0 109.979 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -51.74 -56.12 15.66 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.105 -0.997 . . . . 0.0 108.354 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 7.7 m-85 -68.83 -30.96 69.61 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.604 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -44.6 -44.35 8.27 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 11.6 mttt -87.29 -19.21 28.58 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.464 -1.021 . . . . 0.0 109.922 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.527 ' O ' ' CG ' ' B' ' 19' ' ' GLU . . . -98.93 -0.06 42.99 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.698 ' CZ2' HG23 ' B' ' 17' ' ' VAL . 0.3 OUTLIER -119.21 -47.37 2.47 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.283 -0.886 . . . . 0.0 108.611 179.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.698 HG23 ' CZ2' ' B' ' 16' ' ' TRP . 0.4 OUTLIER -63.79 -41.49 92.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.364 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.543 ' O ' ' ND2' ' B' ' 22' ' ' ASN . . . -65.56 -6.02 26.51 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 108.701 -1.759 . . . . 0.0 108.701 178.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.527 ' CG ' ' O ' ' B' ' 15' ' ' ALA . 3.1 mm-40 -105.94 -68.52 0.87 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.208 -1.172 . . . . 0.0 109.545 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.613 ' HB ' ' CZ3' ' B' ' 16' ' ' TRP . 25.5 mt -64.29 -52.29 57.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-O 121.617 0.723 . . . . 0.0 109.904 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.589 ' HB2' ' O ' ' B' ' 17' ' ' VAL . 0.0 OUTLIER -47.94 -23.11 0.7 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.504 -0.747 . . . . 0.0 109.86 -179.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.543 ' ND2' ' O ' ' B' ' 18' ' ' GLY . 6.0 p30 -132.27 26.38 4.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.303 179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.486 ' OG ' ' HA ' ' B' ' 20' ' ' ILE . 34.6 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.328 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 2' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 2' ' ' ILE . 0.5 OUTLIER -163.44 63.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.272 -1.134 . . . . 0.0 109.271 179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -154.65 22.9 0.63 Allowed Glycine 0 N--CA 1.489 2.18 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.434 ' HB2' ' HE3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -134.12 -43.81 0.79 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.567 -0.961 . . . . 0.0 108.517 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.673 ' HB3' ' HA ' ' B' ' 16' ' ' TRP . 8.5 m-85 -67.54 -20.41 65.41 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.391 -0.818 . . . . 0.0 109.261 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.7 ' HA ' HD11 ' B' ' 20' ' ' ILE . 0.5 OUTLIER -100.42 -1.4 35.99 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.236 -0.915 . . . . 0.0 110.36 -178.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.433 ' O ' ' HD2' ' A' ' 11' ' ' LYS . 16.3 m-70 -136.84 -30.87 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.119 -0.988 . . . . 0.0 110.124 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.41 ' N ' ' O ' ' A' ' 4' ' ' LYS . 1.1 t -106.12 -32.87 8.05 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.059 -1.025 . . . . 0.0 109.636 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.63 ' CB ' ' HA ' ' A' ' 5' ' ' TYR . . . -76.24 -59.42 2.77 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.182 -0.948 . . . . 0.0 109.16 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.522 ' HD3' ' HE2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -40.4 -35.25 0.41 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.541 -179.735 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.522 ' HE2' ' HD3' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -61.51 -64.17 1.03 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.26 -0.9 . . . . 0.0 108.742 179.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.531 ' N ' ' CD1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -66.82 -34.04 76.93 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.16 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.608 ' HA2' ' CD1' ' A' ' 16' ' ' TRP . . . -42.4 -37.82 2.65 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.13 -21.01 20.66 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.404 -1.057 . . . . 0.0 110.287 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.561 ' O ' ' HG2' ' A' ' 19' ' ' GLU . . . -95.15 -52.93 3.99 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.044 -1.035 . . . . 0.0 110.277 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TRP . . . . . 0.757 ' HA ' ' HB3' ' B' ' 5' ' ' TYR . 1.4 p-90 -51.31 -42.63 61.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.551 -0.718 . . . . 0.0 109.87 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG22 ' CB ' ' A' ' 21' ' ' MET . 0.8 OUTLIER -56.25 -51.0 68.42 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 O-C-N 121.184 -0.947 . . . . 0.0 108.923 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 17' ' ' VAL . . . -58.03 -14.26 16.94 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' A' ' 15' ' ' ALA . 35.2 mm-40 -90.01 -63.93 1.21 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.261 -1.141 . . . . 0.0 108.24 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.599 ' HB ' ' CZ3' ' A' ' 16' ' ' TRP . 18.8 mt -74.6 -49.05 32.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.765 -179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.748 ' CB ' HG22 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.74 -11.22 53.72 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.723 -0.611 . . . . 0.0 110.334 -178.803 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 18' ' ' GLY . 9.2 t30 -110.04 -27.26 9.29 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.075 . . . . 0.0 109.481 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 117.961 -1.019 . . . . 0.0 109.498 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ILE . . . . . 0.426 HD13 ' HG ' ' B' ' 6' ' ' LEU . 1.0 OUTLIER -139.03 110.13 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.188 -1.184 . . . . 0.0 109.585 -179.885 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.86 -19.59 1.01 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.427 ' O ' ' N ' ' B' ' 9' ' ' ALA . 0.0 OUTLIER -114.29 -19.48 11.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.949 -1.324 . . . . 0.0 108.815 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.757 ' HB3' ' HA ' ' A' ' 16' ' ' TRP . 3.9 m-85 -79.58 -25.0 41.66 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.468 -0.77 . . . . 0.0 109.774 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' LEU . . . . . 0.547 ' C ' ' CG ' ' B' ' 7' ' ' HIS . 1.1 mm? -111.26 12.84 21.72 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.252 -0.905 . . . . 0.0 110.014 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' HIS . . . . . 0.547 ' CG ' ' C ' ' B' ' 6' ' ' LEU . 4.5 m-70 -152.66 16.95 0.6 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.133 -0.98 . . . . 0.0 109.45 -179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' SER . . . . . . . . . . . . . 3.5 m -165.6 -38.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.343 -0.848 . . . . 0.0 109.216 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ALA . . . . . 0.643 ' HB2' ' HA ' ' B' ' 5' ' ' TYR . . . -61.98 -65.84 0.63 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.254 -0.904 . . . . 0.0 109.087 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LYS . . . . . 0.56 ' HG3' ' CD1' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -31.73 -44.41 0.08 Allowed 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.709 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.76 -64.39 0.87 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.995 -1.066 . . . . 0.0 108.994 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' PHE . . . . . 0.524 ' O ' ' N ' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -70.68 -37.75 73.68 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.195 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.611 ' HA2' ' CD1' ' B' ' 16' ' ' TRP . . . -43.07 -36.63 2.79 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 12.8 mmmt -97.72 -13.36 21.48 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.261 -1.141 . . . . 0.0 109.983 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ALA . . . . . 0.528 ' O ' ' HG2' ' B' ' 19' ' ' GLU . . . -103.44 -49.87 3.59 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.119 -0.988 . . . . 0.0 109.639 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TRP . . . . . 0.673 ' HA ' ' HB3' ' A' ' 5' ' ' TYR . 1.1 p-90 -51.72 -43.94 63.03 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.419 -0.801 . . . . 0.0 109.793 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.634 ' N ' ' CD2' ' B' ' 16' ' ' TRP . 0.5 OUTLIER -58.21 -48.89 83.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.067 -1.021 . . . . 0.0 108.894 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLY . . . . . 0.55 ' N ' ' CG1' ' B' ' 17' ' ' VAL . . . -58.32 -13.63 16.54 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.005 -1.638 . . . . 0.0 109.005 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' B' ' 15' ' ' ALA . 3.9 mm-40 -93.9 -65.43 0.99 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.509 -0.995 . . . . 0.0 108.651 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.7 HD11 ' HA ' ' A' ' 6' ' ' LEU . 5.4 mt -69.38 -50.36 52.29 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 CA-C-O 121.504 0.668 . . . . 0.0 109.548 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' MET . . . . . 0.628 ' HB2' HG22 ' B' ' 17' ' ' VAL . 0.1 OUTLIER -57.02 -15.45 5.12 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.532 -0.73 . . . . 0.0 109.799 -179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' B' ' 18' ' ' GLY . 0.2 OUTLIER -103.02 -46.75 4.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.154 -0.966 . . . . 0.0 109.233 179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' B' ' 22' ' ' ASN . 1.8 t . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.034 -0.984 . . . . 0.0 109.397 -179.852 . . . . . . . . 1 1 . 1 stop_ save_